<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Viruses</journal-id><journal-id journal-id-type="iso-abbrev">Viruses</journal-id><journal-id journal-id-type="publisher-id">viruses</journal-id><journal-title-group><journal-title>Viruses</journal-title></journal-title-group><issn pub-type="epub">1999-4915</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.3390/v11020131</article-id><article-id pub-id-type="publisher-id">viruses-11-00131</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Control of Acute Arboviral Infection by Natural Killer Cells</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Maucourant</surname><given-names>Christopher</given-names></name><xref ref-type="aff" rid="af1-viruses-11-00131">1</xref></contrib><contrib contrib-type="author"><name><surname>Petitdemange</surname><given-names>Caroline</given-names></name><xref ref-type="aff" rid="af2-viruses-11-00131">2</xref></contrib><contrib contrib-type="author"><name><surname>Yssel</surname><given-names>Hans</given-names></name><xref ref-type="aff" rid="af1-viruses-11-00131">1</xref></contrib><contrib contrib-type="author"><name><surname>Vieillard</surname><given-names>Vincent</given-names></name><xref ref-type="aff" rid="af1-viruses-11-00131">1</xref><xref rid="c1-viruses-11-00131" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-viruses-11-00131"><label>1</label>Sorbonne Universit&#x000e9;, UPMC Univ Paris 06, Inserm U1135, CNRS ERL8255, Centre d&#x02019;Immunologie et des Maladies Infectieuses (CIMI-Paris), 75013 Paris, France; <email>maucourantchristopher@hotmail.fr</email> (C.M.); <email>hans.yssel@inserm.fr</email> (H.Y.)</aff><aff id="af2-viruses-11-00131"><label>2</label>Institut Gustave Roussy, CNRS UMR9196, Unit&#x000e9; Physiologie et Pathologie Mol&#x000e9;culaires des R&#x000e9;trovirus Endog&#x000e8;nes et Infectieux, 94800 Villejuif, France; <email>caroline.petitdemange@gmail.com</email></aff><author-notes><corresp id="c1-viruses-11-00131"><label>*</label>Correspondence: <email>vincent.vieillard@sorbonne-universite.fr</email>; Tel.: +33-1-42-17-75-24</corresp></author-notes><pub-date pub-type="epub"><day>31</day><month>1</month><year>2019</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2019</year></pub-date><volume>11</volume><issue>2</issue><elocation-id>131</elocation-id><history><date date-type="received"><day>14</day><month>12</month><year>2018</year></date><date date-type="accepted"><day>31</day><month>1</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; 2019 by the authors.</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>The recent explosive pandemic of chikungunya virus (CHIKV) followed by Zika (ZIKV) virus infections occurring throughout many countries represents the most unexpected arrival of arthropod-borne viral diseases in the past 20 years. Transmitted through the bite of <italic>Aedes</italic> mosquitoes, the clinical picture associated with these acute arbovirus infections, including Dengue (DENV), CHIKV and ZIKV, ranges from classical febrile illness to life-threatening disease. Whereas ZIKV and CHIKV-mediated infections have previously been recognized as relatively benign diseases, in contrast to Dengue fever, recent epidemic events have brought waves of increased morbidity and mortality leading to a serious public health problem. Although the host immune response plays a crucial role in controlling infections, it may also promote viral spread and immunopathology. Here, we review recent developments in our understanding of the immune response, with an emphasis on the early antiviral immune response mediated by natural killer cells and emphasize their Janus-faced effects in the control of arbovirus infection and pathogenesis. Improving our understanding knowledge on of the mechanisms that control viral infection is crucial in the current race against the globalization of arbovirus epidemics.</p></abstract><kwd-group><kwd>natural killer cells</kwd><kwd>arboviruses</kwd><kwd>interferon-&#x003b3;</kwd><kwd>cytotoxicity</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-viruses-11-00131"><title>1. Introduction</title><sec id="sec1dot1-viruses-11-00131"><title>1.1. Emerging Arboviruses: A Global Public Health Threat</title><p>Pathogens transmitted by mosquitoes constitute a profound and growing health burden according to the World Health Organization (<uri xlink:href="http://www.who.int/mediacentre/factsheets/fs387/en/">http://www.who.int/mediacentre/factsheets/fs387/en/</uri>). Urbanization, poverty, globalization, migration and climate changes are widely recognized as contributors to the spread of infections by arthropod-borne viruses (arboviruses). These latter are genetically highly diverse and represent one of the largest virus groups, with nearly 500 members known at present throughout the world. While many arboviruses do not currently appear to be pathogens, they provide an immense resource for the emergence of new pathogens in the future To date, the most medically important mosquito-borne arboviruses are grouped in two major families: (i) the <italic>Flaviviridae</italic> (genus <italic>flavivirus</italic>) which includes West Nile (WNV), yellow fever (YFV), dengue (DENV) and Zika (ZIKV) viruses and (ii) the <italic>Togaviridae</italic> (genus <italic>alphavirus</italic>) to which belong Chikungunya (CHIKV), Ross River (RRV) and Sindbis (SINV) viruses [<xref rid="B1-viruses-11-00131" ref-type="bibr">1</xref>,<xref rid="B2-viruses-11-00131" ref-type="bibr">2</xref>]. A more complete list of arboviruses and their geographical repartition is shown in <xref ref-type="fig" rid="viruses-11-00131-f001">Figure 1</xref>. Of concern, the frequency and magnitude of arboviral epidemics has increased in both established and recently colonized geographic areas. Globally, millions of people are infected each year by arboviruses that cause epidemics, spread by the day-biting of the <italic>Aedes (Ae.) aegypti</italic> mosquito, which is the primary vector [<xref rid="B3-viruses-11-00131" ref-type="bibr">3</xref>]. This mosquito evolved from the sylvan African <italic>Ae. formosus</italic> to become an anthropophilic species that breeds in urban environments and feeds primarily on humans [<xref rid="B4-viruses-11-00131" ref-type="bibr">4</xref>]. In contrast to the typically sylvatic outbreaks of CHIKV that occur in Africa, a single amino acid mutation in the E1 envelop protein adapted the CHIKV to <italic>Ae. albopictus</italic>, a vector that readily adapts to diverse environmental conditions. Importantly, the past three decades have seen a dramatic global expansion in the geographic distribution of <italic>Ae. albopictus</italic> that continues today [<xref rid="B5-viruses-11-00131" ref-type="bibr">5</xref>,<xref rid="B6-viruses-11-00131" ref-type="bibr">6</xref>].</p><p>The intensification of the globalization process has resulted in a sharp increase in the spread of these infectious diseases with a staggering economic burden. For example, DENV causes more than 50 million infections yearly with more than 13,000 fatal cases for an annual global cost of US $ 9 billion [<xref rid="B7-viruses-11-00131" ref-type="bibr">7</xref>]. In addition, the recent outbreaks of ZIKV, associated with neurological disorders and neonatal malformations in Latin America, YFV outbreaks in Angola and Brazil, WNV in North America, as well as the emergence of CHIKV from sub-Saharan Africa in the not-too-distant past and its relatively recent arrival in the Americas and Europe have propelled arboviruses in the news and placed them at the top of social, political and public health agendas. The intensification of the globalization process has resulted in a sharp increase in the spread of infectious diseases to populations lacking native immunity.</p></sec><sec id="sec1dot2-viruses-11-00131"><title>1.2. Host Immune Responses to Mosquito Bites and Arbovirus Infection</title><p>Despite their considerable diversity, mosquito-borne viruses share a common attribute: transmission via the skin at the site of the mosquito bite. <xref ref-type="fig" rid="viruses-11-00131-f002">Figure 2</xref> shows that after the bite, the majority of the virus is directly deposited into the extracellular space of the dermis, which represents the first stage of infection. Both DENV and ZIKV have been shown to infect dermal dendritic cells (DCs) and although there are no reports of YFV infecting Langerhans cells, it can nevertheless infect myeloid DCs. Viral entry into susceptible cells during ZIKV infection is mediated by DC-SIGN but appears to be DC-SIGN-independent in the case of DENV and YFV [<xref rid="B8-viruses-11-00131" ref-type="bibr">8</xref>]. It has been shown that CHIKV is able to replicate in epithelial and endothelial cells and, to a lesser extent, monocyte-derived macrophages and that viral entry into these cells was mediated by several receptors including prohibitin, phosphatidylserine-mediated virus entry-enhancing receptors and glycosaminoglycans [<xref rid="B9-viruses-11-00131" ref-type="bibr">9</xref>]. Although the host rapidly mounts a response to control the virus in the dermis, the virus is able to disseminate quickly to different relevant lymphoid and non-lymphoid tissues via the peripheral blood (<xref ref-type="fig" rid="viruses-11-00131-f002">Figure 2</xref>). In a zebrafish model, it was shown that CHIKV rapidly disseminates to various organs within approximately 14 h after infection [<xref rid="B10-viruses-11-00131" ref-type="bibr">10</xref>]. During this silent incubation period, the viral load in the circulation increases rapidly to reach a high serum levels of infectious particles. The acute phase of arbovirus infection is accompanied by an early type I interferon (IFN) response [<xref rid="B11-viruses-11-00131" ref-type="bibr">11</xref>]. Indeed, mice defective in IFNAR signalling succumb to most arbovirus infections within a few days [<xref rid="B12-viruses-11-00131" ref-type="bibr">12</xref>].</p><p>Concomitantly with the production of type I IFN, trauma associated with mosquito bites and the presence of salivary protein(s) induce a multistep recruitment of leukocytes that is initiated with mast cell degranulation and the recruitment of neutrophils that express high levels of the key proinflammatory cytokine interleukin-1&#x003b2;, which are important for the induction of inflammatory responses [<xref rid="B13-viruses-11-00131" ref-type="bibr">13</xref>,<xref rid="B14-viruses-11-00131" ref-type="bibr">14</xref>]. It is important, however, to note that results obtained from cytokine analyses in patients with arbovirus infection are often contradictory. Thus, For the same viral infection, discrepancies between studies could reflect different genetic backgrounds, heterogeneous sanitary conditions, patient management strategies or differences in laboratory techniques [<xref rid="B6-viruses-11-00131" ref-type="bibr">6</xref>,<xref rid="B15-viruses-11-00131" ref-type="bibr">15</xref>]. The inflammatory process that occurs following the spread of virus from blood to other tissues causes the recruitment of inflammatory monocytes and natural killer (NK) cells (<xref ref-type="fig" rid="viruses-11-00131-f002">Figure 2</xref>), in association with the development of several clinical symptoms, including headache, back and muscle aches, nausea and vomiting, rash, arthralgia and myalgia [<xref rid="B6-viruses-11-00131" ref-type="bibr">6</xref>,<xref rid="B11-viruses-11-00131" ref-type="bibr">11</xref>,<xref rid="B14-viruses-11-00131" ref-type="bibr">14</xref>,<xref rid="B15-viruses-11-00131" ref-type="bibr">15</xref>]. However, despite certain clinical similarities, there are also differences in the most severe disease manifestations such as the prominent and prolonged arthralgia with CIKV infection, haemorrhagic fever with DENV infection and microcephaly and other neurological manifestations with ZIKV infection [<xref rid="B1-viruses-11-00131" ref-type="bibr">1</xref>,<xref rid="B6-viruses-11-00131" ref-type="bibr">6</xref>,<xref rid="B16-viruses-11-00131" ref-type="bibr">16</xref>].</p><p>It is however important to note that infection by arboviruses induces a long-term protection, as recently demonstrated for CHIKV [<xref rid="B17-viruses-11-00131" ref-type="bibr">17</xref>]. DENV is an excellent example of the opposite situation, with the presence of four different serotypes (DENV-1 to DENV-4). Infection with any of the four dengue serotypes induces protective immunity to the priming serotype but does not confer long-term protection against infection by other serotypes. Furthermore, heterotypic secondary DENV infection, with a DENV type distinct from the primary infecting type, is the greatest risk factor for Dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS) [<xref rid="B18-viruses-11-00131" ref-type="bibr">18</xref>]. It has been hypothesized that the worsening of disease following a secondary infection is due to antibody-dependent enhancement (ADE) (See below). Recently, Katzelnick et al. [<xref rid="B19-viruses-11-00131" ref-type="bibr">19</xref>] demonstrated that the level of pre-existing anti-DENV antibodies is directly associated with the severity of secondary DENV disease in humans.</p></sec><sec id="sec1dot3-viruses-11-00131"><title>1.3. NK Cells: A Critical First-Line Defence of the Immune System against Viral Infections</title><p>NK cells constitute the proverbial first-line defence against a variety of viral infections because of their unique centred position in the immune system, NK cells are considered innate short-lived effectors with a turnover time of approximately 2 weeks, compared to months or years for some T cell subsets [<xref rid="B20-viruses-11-00131" ref-type="bibr">20</xref>,<xref rid="B21-viruses-11-00131" ref-type="bibr">21</xref>,<xref rid="B22-viruses-11-00131" ref-type="bibr">22</xref>]. Upon activation and recruitment to the site of infection, the canonical function of NK cells is cytolysis. Consistent with the critical nature of NK cell-mediated killing, impaired cytolysis is the primary diagnostic criterion in patients with functional NK cell deficiencies, associated with herpes virus susceptibility [<xref rid="B23-viruses-11-00131" ref-type="bibr">23</xref>,<xref rid="B24-viruses-11-00131" ref-type="bibr">24</xref>]. NK cells also play both antiviral and regulatory roles via the release of soluble factors and operate via a balance of inhibitory and activating signals that enable them to detect and lyse virus-infected target cells while sparing normal cells [<xref rid="B25-viruses-11-00131" ref-type="bibr">25</xref>,<xref rid="B26-viruses-11-00131" ref-type="bibr">26</xref>].</p><p>Importantly, during acute infection the quantity of NK cells can significantly decrease in the peripheral blood, suggesting that NK cells are recruited from the periphery to sites of infection, in order to produce cytokines and become cytotoxic. The role of resident and circulating NK cells in the target tissues remains as yet elusive; however, the recent identification of markers specific for human tissue-resident NK cells, such as CD69, CD103 (&#x003b1;E integrin) and CD49 (&#x003b1;1 integrin) [<xref rid="B27-viruses-11-00131" ref-type="bibr">27</xref>] is crucial for further studies on NK cells during viral infection.</p><p>Under normal immune surveillance, NK cells express inhibitory receptors, including killer Ig-like receptors (KIR-L), ILT-2 and the CD94:NKG2A heterodimer that recognize primarily classical and non-classical major histocompatibility complex (MHC) class I molecules. This &#x0201c;missing-self&#x0201d; recognition counterbalances cytotoxic CD8<sup>+</sup> T-cell recognition restricted by pathogen-induced loss of MHC class I molecules. NK cells become functional when stimulatory signals, induced following the triggering of activating receptors, outweigh MHC class I-mediated inhibition. Several of these activating receptors have been characterized, including activating KIRs (KIR-S), which are highly homologous to their inhibitory counterparts in the extracellular domain, characterized by a short cytoplasmic tail lacking ITIMs, that interacts with DAP-12, a signalling polypeptide that induces NK cell activation. A growing number of studies point to a significant association between the presence of activating KIRs and the clinical outcome of some human diseases, including viral infections [<xref rid="B28-viruses-11-00131" ref-type="bibr">28</xref>]. Interestingly, it was recently reported by Naiyer et al. [<xref rid="B29-viruses-11-00131" ref-type="bibr">29</xref>] that HLA-C*0102 presents a highly conserved peptide derived from the helicase motif 1b region of related flaviviruses, including DENGV, ZIKV, YFV and Japanese encephalitis viruses, to KIR2DS2. The other activating NK receptors are: NKG2C, recently defined as the key receptor of the adaptive NK cells expended after viral infections, NKG2D and the natural cytotoxicity receptors (NCRs) NKp30, NKp44 and NKp46, in addition to specific co-receptors [<xref rid="B26-viruses-11-00131" ref-type="bibr">26</xref>,<xref rid="B30-viruses-11-00131" ref-type="bibr">30</xref>]. Their ligands are diverse and their expression mainly upregulated by cellular stress, which allows NK cells to specifically eliminate harmful or unhealthy host cells. The multitude of receptors that are expressed by defined NK cell subsets and that binds to viral ligands illustrates a specific mode of recognition.</p><p>The relevance of this recognition is highlighted by mechanisms evolved by viruses to evade the host immune system and diminish expression of stress ligands. This array of receptors also generates a vast diversity in the NK repertoire, arguing that single-cell diversity enhances their ability to fulfil this role. The diversity of the T- or B-cell repertoire is captured in a single antigen receptor, whereas NK cells, by contrast, are diverse at a single-cell level. Consequently, based on the expression of 28 cell surface receptors, the NK cell repertoire is composed of up to 3 &#x000d7; 10<sup>4</sup> possible subpopulations [<xref rid="B31-viruses-11-00131" ref-type="bibr">31</xref>].</p><p>The importance of the antiviral response mediated by NK cells in humans has essentially been indicated by indirect evidence, including the following:
<list list-type="simple"><list-item><label>(1)</label><p>Most of the primary deficiencies in NK cell frequency or function are associated with an unusual susceptibility to herpes viruses [<xref rid="B23-viruses-11-00131" ref-type="bibr">23</xref>,<xref rid="B24-viruses-11-00131" ref-type="bibr">24</xref>].</p></list-item><list-item><label>(2)</label><p>KIR and HLA genotypes are associated with susceptibility or resistance to a large panel of viral infections, including arboviruses [<xref rid="B32-viruses-11-00131" ref-type="bibr">32</xref>,<xref rid="B33-viruses-11-00131" ref-type="bibr">33</xref>,<xref rid="B34-viruses-11-00131" ref-type="bibr">34</xref>].</p></list-item><list-item><label>(3)</label><p>NK cells can control a viral infection in the absence of a T cell response. This was shown in a 3-month-old girl with a T<sup>&#x02212;</sup>B<sup>+</sup>NK<sup>+</sup> severe combined immunodeficiency phenotype who recovered from cytomegalovirus (CMV) infection without antiviral therapy. In this patient, the high number of NK cells (&#x0003e;2 &#x000d7; 10<sup>10</sup>/L) present at the peak of viremia, as well as the correlation between viral load and the number of NK cells during follow-up, were suggestive of a causal relation [<xref rid="B35-viruses-11-00131" ref-type="bibr">35</xref>].</p></list-item><list-item><label>(4)</label><p>Adaptive NKG2C<sup>+</sup> NK cells can be expanded in response to different viral infections in the context of human CMV seropositivity [<xref rid="B36-viruses-11-00131" ref-type="bibr">36</xref>,<xref rid="B37-viruses-11-00131" ref-type="bibr">37</xref>,<xref rid="B38-viruses-11-00131" ref-type="bibr">38</xref>]. These hyper-reactive and long-lived NK cells have been described after certain viral infections and are able to mount stronger protective responses upon re-encounter of the same pathogen, at least in mice [<xref rid="B39-viruses-11-00131" ref-type="bibr">39</xref>,<xref rid="B40-viruses-11-00131" ref-type="bibr">40</xref>,<xref rid="B41-viruses-11-00131" ref-type="bibr">41</xref>,<xref rid="B42-viruses-11-00131" ref-type="bibr">42</xref>], which could redefine the notion of immunological memory for NK cells. These adaptive NK cells will be discussed in further detail later, in the context of arbovirus infection.</p></list-item></list></p><p>Altogether, these examples illustrate that NK cells can integrate a diversity of cues that contribute to their role during infection and in particular by arboviruses.</p></sec></sec><sec id="sec2-viruses-11-00131"><title>2. NK Cell Responses following Arbovirus Infection</title><sec id="sec2dot1-viruses-11-00131"><title>2.1. Alphaviviruses</title><p>Alphaviruses are members of the <italic>Togaviridae</italic> family of single-stranded, positive-sense RNA viruses that make up a major group of medically important arboviruses. Alphaviruses impact human health around the world, often in areas with heavy disease burdens from other arboviruses that cause infections that present similar early clinical symptoms. Countries in the Americas and the Caribbean are experiencing a waning epidemic encompassing over 2 million suspected infections from the arrival of CHIKV in 2013, an alphavirus associated with chronic and debilitating polyarthralgias (Pan American Health Organization 2017. <uri xlink:href="http://www.paho.org/hq/index.php?option=com_topics&#x00026;view=readall&#x00026;cid=5927&#x00026;Itemid=40931&#x00026;lang=en">http://www.paho.org/hq/index.php?option=com_topics&#x00026;view=readall&#x00026;cid=5927&#x00026;Itemid=40931&#x00026;lang=en</uri>). In 2008, CHIKV was listed as a US National Institute of Allergy and Infectious Diseases category C priority pathogen. Persistent joint pain is a common symptom also caused by other related pathogen alphaviruses, such as RRV, O&#x02019;nyong-nyong virus and Mayaro virus, which are poised to become the next emerging pathogen [<xref rid="B11-viruses-11-00131" ref-type="bibr">11</xref>,<xref rid="B43-viruses-11-00131" ref-type="bibr">43</xref>,<xref rid="B44-viruses-11-00131" ref-type="bibr">44</xref>]. Intriguingly, outbreaks were mostly reported to be unpredictable, with an interval of several decades between major events; the precise factors of alphavirus emergence are unclear but it can hypothesized that, in addition to ecologic and virus-linked factors, the immune status of the affected populations plays a key role both in the intensity and periodicity of recurrence.</p><p>To date, the role of NK cells was mostly examined in detail for CHIKV infection. Although we and others have shown that NK cells mount an early and efficient protective response following CHIKV infection, their contribution to viral-induced pathology has been reported as well [<xref rid="B45-viruses-11-00131" ref-type="bibr">45</xref>,<xref rid="B46-viruses-11-00131" ref-type="bibr">46</xref>,<xref rid="B47-viruses-11-00131" ref-type="bibr">47</xref>,<xref rid="B48-viruses-11-00131" ref-type="bibr">48</xref>]. A few days after the onset of infection, NK cells display an activated profile [<xref rid="B45-viruses-11-00131" ref-type="bibr">45</xref>,<xref rid="B49-viruses-11-00131" ref-type="bibr">49</xref>] with increased expression of late-differentiation makers such as CD57, ILT-2 and CD8a. By contrast, expression of immature receptors such as NKG2A and CD161 is decreased together with the activating NKp30 and NKp46 receptors [<xref rid="B45-viruses-11-00131" ref-type="bibr">45</xref>,<xref rid="B46-viruses-11-00131" ref-type="bibr">46</xref>], as has been previously observed in other viral infections [<xref rid="B20-viruses-11-00131" ref-type="bibr">20</xref>,<xref rid="B50-viruses-11-00131" ref-type="bibr">50</xref>]. More intriguingly, CHIKV infection skews the NK cell receptor repertoire toward expression of the activating CD94/NKG2C receptor, which is usually very poorly or not at all expressed on NK cells of healthy donors. Initially, Guma et al. [<xref rid="B51-viruses-11-00131" ref-type="bibr">51</xref>] described a skewing of the NK cell repertoire toward adaptive NK cells that express the activating CD94/NKG2C receptor in HCMV seropositive individuals. Similar observations have been made in the context of CHIKV [<xref rid="B45-viruses-11-00131" ref-type="bibr">45</xref>], Hantavirus [<xref rid="B52-viruses-11-00131" ref-type="bibr">52</xref>] and viral hepatitis B and C [<xref rid="B53-viruses-11-00131" ref-type="bibr">53</xref>,<xref rid="B54-viruses-11-00131" ref-type="bibr">54</xref>]. Until now, the presence and expansion of adaptive NK cells have almost exclusively been associated with prior exposure to HCMV or its reactivation [<xref rid="B55-viruses-11-00131" ref-type="bibr">55</xref>]. This expansion seems partially driven by the increase in expression of HLA-E, the ligand of NKG2C, together with responsiveness of the cells to IL-12 and/or IL-15 [<xref rid="B56-viruses-11-00131" ref-type="bibr">56</xref>,<xref rid="B57-viruses-11-00131" ref-type="bibr">57</xref>]. In addition, several recent studies have demonstrated that sequence variation in peptides presented by HLA-E could affect activation and antibody-driven effector function of adaptive NK cells [<xref rid="B20-viruses-11-00131" ref-type="bibr">20</xref>,<xref rid="B58-viruses-11-00131" ref-type="bibr">58</xref>]. Although key questions regarding the regulation and function of adaptive NK cells remain, their expansion is clearly associated with the development of memory NK cells, at least in certain experimental animal models [<xref rid="B59-viruses-11-00131" ref-type="bibr">59</xref>,<xref rid="B60-viruses-11-00131" ref-type="bibr">60</xref>].</p><p>It is clear that NK cells in CHIKV infection are strongly cytotoxic without producing IFN-&#x003b3;, thereby suggesting a prominent role of NK cells in the control and destruction of virus-infected target cells [<xref rid="B45-viruses-11-00131" ref-type="bibr">45</xref>,<xref rid="B47-viruses-11-00131" ref-type="bibr">47</xref>]. Paradoxically perhaps, the lack of IFN-&#x003b3; in the microenvironment could alter or delay initiation of the adaptive immune response and be associated with a delay in the resolution of persistent symptoms during the chronic phase of infection [<xref rid="B45-viruses-11-00131" ref-type="bibr">45</xref>]. Thus, in an experimental mouse model of CHIKV infection, extension of oedema was correlated with high NK activity, whereas the depletion of NK cells significantly reduced acute joint pathology, thus corroborating the deleterious role of NK cells in driving virus-induced pathology [<xref rid="B61-viruses-11-00131" ref-type="bibr">61</xref>]. These data are consistent with those obtained in degenerative joint disease associated with osteoarthritis in which synovial tissue-infiltrating NK cells displayed impaired IFN-&#x003b3; production, suggesting that NK cells contribute to the evolution of disease [<xref rid="B62-viruses-11-00131" ref-type="bibr">62</xref>,<xref rid="B63-viruses-11-00131" ref-type="bibr">63</xref>].</p><p>Overall, NK cells appear to be beneficial in the acute phase of CHIKV infection. Nevertheless, NK cells could contribute to immunopathologic mechanisms by infiltrating synovial tissues and maintaining an inflammatory environment that could contribute to the development of chronic articular inflammation in CHIKV-infected patients.</p></sec><sec id="sec2dot2-viruses-11-00131"><title>2.2. Flaviviruses</title><p>Among the most pathogenic flavivirus<italic>es</italic> in humans, the archetype, YFV, causes jaundice in those people who are severely affected. An effective and affordable vaccine providing long-lasting immunity has been widely available for more than 50 years [<xref rid="B64-viruses-11-00131" ref-type="bibr">64</xref>]. This 17D vaccine is one of the most effective vaccines developed to date; 99% of recipients are protected for more than 10 years after a single vaccination (<uri xlink:href="http://www.who.int/mediacentre/factsheets/fs100/en/">http://www.who.int/mediacentre/factsheets/fs100/en/</uri>). However, despite the success of this vaccine, YFV continues to circulate in the tropical jungles of Africa and South America and re-emerges regularly to infect na&#x000ef;ve persons. WNV is even more widely dispersed because it infects a range of mosquito, mammalian, avian and reptilian species. This virus has attracted attention as a major pathogen following an outbreak of fever and encephalitis in New York, USA in 1999, where deaths in horses, birds and humans were reported. Within 5 years, the virus had dispersed throughout the Americas [<xref rid="B65-viruses-11-00131" ref-type="bibr">65</xref>]. DENV fever remains an important disease caused by four closely related viruses, DENV 1&#x02013;4, for which no DENV-specific therapies are available. The sole approved DENV vaccine elicits protection in people with prior DENV exposure but not in na&#x000ef;ve individuals in which it has been associated with more cases of DENV haemorrhagic fever upon subsequent infection [<xref rid="B66-viruses-11-00131" ref-type="bibr">66</xref>]. Another important question concerns ZIKV, which was confined as a low-pathogenic arbovirus for a long period of time but was recently declared as a public health emergency by the WHO. The reason for this dramatic change was its recent spread worldwide and its link to Guillain-Barr&#x000e9; syndrome in adults and multiple neurodevelopmental defects, including microcephaly in infants born of mothers infected during the first trimester of pregnancy [<xref rid="B16-viruses-11-00131" ref-type="bibr">16</xref>,<xref rid="B66-viruses-11-00131" ref-type="bibr">66</xref>].</p><p>As described for other human pathogenic arboviruses, recovery from flavivirus infections depends on the host&#x02019;s ability to mount effective innate antiviral responses that can eliminate or at least control, the virus. Following natural infection by an infected mosquito, viral particles are introduced into the subcutaneous space, where resident DCs are one of the first cell types to be infected by flaviviruses such as DENV or ZIKV. The DCs are specialized in the production of a robust level of type I IFN. Several lines of evidence have indicated that the type I IFN system is the central mediator of protection. First, studies with DENV-infected patient samples have shown that, during the early febrile period, high levels of type I IFN is observed in the serum of DENV-infected patients [<xref rid="B67-viruses-11-00131" ref-type="bibr">67</xref>,<xref rid="B68-viruses-11-00131" ref-type="bibr">68</xref>]. In addition to direct antiviral effects, type I IFN also mediates a variety of immunoregulatory effects, including regulation of NK development and maturation and activation of NK cells [<xref rid="B69-viruses-11-00131" ref-type="bibr">69</xref>]. A subsequent local inflammatory response rapidly recruits leukocytes, such as type I-activated NK cells, to the site of infection [<xref rid="B70-viruses-11-00131" ref-type="bibr">70</xref>], which is mediated by a modulation of the expression of specific homing markers in these cells. In particular a decreased expression of CXCR3 is associated with a concomitant increase of CCR10 in DENV<sup>+</sup> patients, as compared to healthy donors; this homing of NK cells appears to be directed to the bone marrow, skin and possibly the lymph nodes [<xref rid="B71-viruses-11-00131" ref-type="bibr">71</xref>]. The tissue-specific localizations are consistent with the generally accepted finding of DENV infection that often results in &#x0201c;petechiae&#x0201d; following resolution of infection A protective role of CXCR3-expressing NK cells appears to be important in DENV, is supported by the high mortality rates and viral load in the brains of CXCR3-deficient mice infected by DENV [<xref rid="B72-viruses-11-00131" ref-type="bibr">72</xref>].</p><p>NK cells have been studied, to various extent, in several flavivirus infections, including DENV, WNV and ZIKV. Generally, in these infections, an early and robust activation of NK cells has been described, suggesting a key role for the latter cells. In DENV-infected patients, early activation of NK cells was also reported, clearly associated with mild dengue disease [<xref rid="B15-viruses-11-00131" ref-type="bibr">15</xref>,<xref rid="B73-viruses-11-00131" ref-type="bibr">73</xref>] and was also observed in children with DENV haemorrhagic fever [<xref rid="B58-viruses-11-00131" ref-type="bibr">58</xref>]. In addition, an extensive phenotypic study has revealed a profound modulation of the NK cell repertoire, including downregulation of the activating receptors NKp30, NKp44, NKp46 and NKG2D in patients infected by DENV [<xref rid="B73-viruses-11-00131" ref-type="bibr">73</xref>,<xref rid="B74-viruses-11-00131" ref-type="bibr">74</xref>] or WNV [<xref rid="B75-viruses-11-00131" ref-type="bibr">75</xref>]. A transient increase in the frequency of adaptive NKG2C<sup>+</sup> NK cells was also found in DENV-infected patients, as previously described for CHIKV, whereas the most prominent response in WNV infection was observed among CD56<sup>dim</sup>CD16<sup>&#x02212;</sup> NK cells, an intermediate state of differentiation [<xref rid="B76-viruses-11-00131" ref-type="bibr">76</xref>]. In a kinetics study, it was observed that the activation state of NK cells in DENV infection was short-lived [<xref rid="B46-viruses-11-00131" ref-type="bibr">46</xref>], suggesting that there is no lasting imprint on the NK cell repertoire, as previously observed in CHIKV infection [<xref rid="B45-viruses-11-00131" ref-type="bibr">45</xref>]. It is important to note that following vaccination with 17D, a live attenuated YFV, NK cell activation peaks at the same time as viral load, 6 days post-vaccination and correlates directly with a rise in plasma type I and type III IFNs. Thereafter, viral load and NK cell responses decline rapidly returning to baseline by day 10 and 15 post-vaccination, respectively [<xref rid="B77-viruses-11-00131" ref-type="bibr">77</xref>,<xref rid="B78-viruses-11-00131" ref-type="bibr">78</xref>].</p><p>In parallel, genetic evidence supports the role of KIRs in flavivirus infection. In studies performed in Gabon, Brazil and Western India, a difference in the frequencies of KIR genes was found in patients infected with DENV, as compared with healthy controls [<xref rid="B33-viruses-11-00131" ref-type="bibr">33</xref>,<xref rid="B79-viruses-11-00131" ref-type="bibr">79</xref>,<xref rid="B80-viruses-11-00131" ref-type="bibr">80</xref>]. Mechanistically, KIR molecules interact with DENV peptides presented on HLA molecules. As observed in many viral infections [<xref rid="B81-viruses-11-00131" ref-type="bibr">81</xref>], an interaction was demonstrated between KIR3DL1 and a conserved NS1 peptide of DENV presented by HLA-B57 [<xref rid="B82-viruses-11-00131" ref-type="bibr">82</xref>]. By contrast, a peptide on the NS3 protein that is conserved in most flaviviruses, including DENV, stabilized HLA-C0102 and interacted with KIR2DS2 resulting in NK cell activation [<xref rid="B29-viruses-11-00131" ref-type="bibr">29</xref>].</p><p>As in several other human viral infections (e.g., CMV, hantavirus, CHIKV and HIV-1), we observed an early accumulation of NKG2C<sup>+</sup> NK cells in association with CD57 following acute infection by DENV-2 in Gabonese patients, in comparison to healthy donors. However, this increase in the frequency of CD57<sup>+</sup>NKG2C<sup>+</sup> NK cells was transient and a return to normal levels occurred rapidly following the acute phase of infection [<xref rid="B46-viruses-11-00131" ref-type="bibr">46</xref>]. Of note, in other flavivirus infections, such as WNV and tick-borne encephalitis (TBEV), another flavivirus transmitted to humans by ticks, specific expansion of NKG2C-expressing NK cells was never observed, even in CMV seropositive donors [<xref rid="B75-viruses-11-00131" ref-type="bibr">75</xref>,<xref rid="B83-viruses-11-00131" ref-type="bibr">83</xref>]. It remains possible that NKG2C<sup>+</sup> NK cells expanded only locally, such as in the central nervous system in a TBEV infection. Indeed, this has been previously observed in patients with celiac disease, in which intraepithelial T cells in the gut lumen expressed high levels of NKG2C, whereas the corresponding T cells in the periphery remained unaffected [<xref rid="B84-viruses-11-00131" ref-type="bibr">84</xref>].</p><p>The results from a principal component analysis based on the expression of different NK cell markers revealed that DENV-2 infection is mostly associated with the modulation of inhibitory KIRs and NKp44, a unique NK receptor only expressed on activated NK cells [<xref rid="B85-viruses-11-00131" ref-type="bibr">85</xref>,<xref rid="B86-viruses-11-00131" ref-type="bibr">86</xref>]. Consistently, a direct interaction of NKp44 and protein E of DENV and WNV has been observed [<xref rid="B87-viruses-11-00131" ref-type="bibr">87</xref>]. These data suggest that this effect might be common for flavivirus infection regardless of the origin of the virus and E protein. Thus, it is likely that a complex balance exists between flavivirus-induced triggering of NK cells and subversion of NK killing as a result of the upregulation of the expression of MHC class I molecules on infected cells [<xref rid="B15-viruses-11-00131" ref-type="bibr">15</xref>,<xref rid="B88-viruses-11-00131" ref-type="bibr">88</xref>]. Increase of MHC class I expression is a hallmark of flavivirus activity, leading to the inhibition of NK cell function. In WNV infections, this modulation is associated with upregulation of NKG2D ligands in infected cultures, suggesting that these stress molecules could play a role in the recognition of infected cells [<xref rid="B75-viruses-11-00131" ref-type="bibr">75</xref>]. Increase of MHC class I expression in ZIKV-infected cells is mediated via the RIGI-IRF3 pathway which can be inhibited by blocking IFN-&#x003b2; [<xref rid="B89-viruses-11-00131" ref-type="bibr">89</xref>]. Other flaviviruses such as WNV are associated with activation of NF-&#x003ba;B, as shown after infection of IFNAR<sup>(&#x02212;/&#x02212;)</sup> cells by WNV [<xref rid="B90-viruses-11-00131" ref-type="bibr">90</xref>]. Furthermore, it was reported that HLA-E is upregulated in ZIKV but not in DENV-infected NK cells, suggesting a differential impact on NKG2A/2C responses [<xref rid="B91-viruses-11-00131" ref-type="bibr">91</xref>]. At least in ZIKV, little or no changes in the expression of other ligands, such as AICL for NKp80; B7H6 for NKp30; CD48 for 2B4; and MHC class I chain-related proteins A and B (MICA and -B molecules for NKG2D) was shown on infected targets [<xref rid="B89-viruses-11-00131" ref-type="bibr">89</xref>]. Because ligands of other NK receptors can be induced by &#x0201c;stress&#x0201d;, further studies are needed to characterize each NK receptor ligand that is induced during flavivirus infection.</p><p>In accordance with the upregulation of MHC class I expression, an increasing number of studies have also reported that flavivirus-infected target cells are unaffected over time, indicating that they are protected from NK cell cytotoxicity. This was shown by us in DENV-2-infected patients [<xref rid="B46-viruses-11-00131" ref-type="bibr">46</xref>] and by Costa et al. in an optimized humanized mouse model, in which IFN-&#x003b3; production by human NK cells was found to be important in controlling DENV replication in the absence of cytotoxicity [<xref rid="B70-viruses-11-00131" ref-type="bibr">70</xref>]. Upregulation of IFN-&#x003b3; production by NK cells was also observed in WNV infection both before and after NK cell expansion [<xref rid="B92-viruses-11-00131" ref-type="bibr">92</xref>]. Similarly, ZIKV-infected cells were unaffected over time, indicating that they were protected from NK cell killing, whereas a strong, time-dependent secretion of IFN-&#x003b3; from NK cells incubated with ZIKV-infected cells was shown [<xref rid="B89-viruses-11-00131" ref-type="bibr">89</xref>]. In another study in Uganda, pre-existing IFN-&#x003b3;-producing NK cells in an activated immune microenvironment were associated with lower viral loads following vaccination against YFV [<xref rid="B78-viruses-11-00131" ref-type="bibr">78</xref>]. Nevertheless, it is important to note that an increased number of NK cells was reported in liver biopsies of patients who died of YFV [<xref rid="B93-viruses-11-00131" ref-type="bibr">93</xref>].</p><p>There are two mechanisms by which a viral infection can be controlled: limiting the rate of production of new virus particles (by blocking viral entry or preventing the infected cell from releasing virus) or increasing the clearance of infected cells or virus. NK cells can play a role in the clearance of infected cells through antibody-dependent cell cytotoxicity (ADCC). In 1984, Kurane et al. [<xref rid="B94-viruses-11-00131" ref-type="bibr">94</xref>] reported that NK cell-mediated lysis of Raji cells particles infected with the DV2 serotype was significantly higher when these cells had been preincubated with DV-immune serum. ADCC activity in plasma from school children in Thailand prior to a secondary infection with DENV appeared to correlate with neutralizing Ab titres and immune protection against secondary DENV-3 infection, although such a correlation was not observed with DENV-2 infection [<xref rid="B95-viruses-11-00131" ref-type="bibr">95</xref>]. Recently, it was reported that the magnitude of ADCC, detected in non-neutralizing patient sera in DENV, is correlated with the expression of CD16 [<xref rid="B96-viruses-11-00131" ref-type="bibr">96</xref>]. Polymorphism of CD16a in positions 48 and 158 has been reported to impact human IgG1 binding and ADCC activity and thus need to be examined in patients infected by DENV. Similarly, NK cells control WNV infection by detecting and lysing NS1-expressing-infected cells through ADCC [<xref rid="B97-viruses-11-00131" ref-type="bibr">97</xref>].</p><p>In DENV, ADCC may be also important during secondary infections by another serotype, when serotype-specific neutralizing antibodies to DENV are present; the four DENV serotypes share 70% sequence homology and thus cross-reactivity is common, known to be an underlying mechanism of elevated immune-pathology associated with severe forms of DENV [<xref rid="B98-viruses-11-00131" ref-type="bibr">98</xref>,<xref rid="B99-viruses-11-00131" ref-type="bibr">99</xref>]. This can cause antibody-dependent enhancement (ADE), in which weakly neutralizing antibodies from the first infection bind to the second serotype and enhance infection of myeloid cells, such as monocytes and macrophages, expressing Fc&#x003b3;R, like CD16 expressed by NK cells [<xref rid="B100-viruses-11-00131" ref-type="bibr">100</xref>]. Recently, Sun et al. have reported the importance of NK cell-mediated ADCC to act as the first line of defence against ADE by showing that NK cell activation occurred concomitantly with the detection of ADE, with elevated expression of CD69 and NKp44 on NK cells [<xref rid="B101-viruses-11-00131" ref-type="bibr">101</xref>]. In this study, a minimal activation of T cells was observed and it was furthermore shown that the magnitude of ADE in monocytes was up to tenfold increased when NK cells were depleted.</p></sec></sec><sec sec-type="conclusions" id="sec3-viruses-11-00131"><title>3. Conclusions</title><p>In this review, we sought to illustrate the role of NK cells in the control of arboviral infections. There are however significant limitations in our current understanding of the mechanisms by which human NK cells recognize the different arboviruses and mediate their antiviral function. Additional studies are needed to further elucidate the molecular mechanisms by which NK cells recognize infected target cells and the nature of the receptor-ligand families that are involved in this process.</p></sec></body><back><notes><title>Author Contributions</title><p>Conceptualization, V.V.; Writing&#x02014;original draft preparation, V.V.; Writing&#x02014;Review &#x00026; Editing, C.M., C.P., H.Y., V.V.; Funding acquisition, H.Y., V.V.</p></notes><notes><title>Funding</title><p>This work was supported by the EU Horizon 2020 ZIKAlliance Program (grant agreement No. 734548).</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-viruses-11-00131"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gould</surname><given-names>E.A.</given-names></name><name><surname>Solomon</surname><given-names>T.</given-names></name></person-group><article-title>Pathogenic flaviviruses</article-title><source>Lancet</source><year>2008</year><volume>371</volume><fpage>500</fpage><lpage>509</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(08)60238-X</pub-id><pub-id pub-id-type="pmid">18262042</pub-id></element-citation></ref><ref id="B2-viruses-11-00131"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strauss</surname><given-names>J.H.</given-names></name><name><surname>Strauss</surname><given-names>E.G.</given-names></name></person-group><article-title>The alphaviruses: Gene expression, replication and evolution</article-title><source>Microbiol. Rev.</source><year>1994</year><volume>58</volume><fpage>491</fpage><lpage>562</lpage><pub-id pub-id-type="pmid">7968923</pub-id></element-citation></ref><ref id="B3-viruses-11-00131"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Musso</surname><given-names>D.</given-names></name><name><surname>Rodriguez-Morales</surname><given-names>A.J.</given-names></name><name><surname>Levi</surname><given-names>J.E.</given-names></name><name><surname>Cao-Lormeau</surname><given-names>V.M.</given-names></name><name><surname>Gubler</surname><given-names>D.J.</given-names></name></person-group><article-title>Unexpected outbreaks of arbovirus infections: Lessons learned from the Pacific and tropical America</article-title><source>Lancet Infect. Dis.</source><year>2018</year><pub-id pub-id-type="doi">10.1016/S1473-3099(18)30269-X</pub-id></element-citation></ref><ref id="B4-viruses-11-00131"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harrington</surname><given-names>L.C.</given-names></name><name><surname>Buonaccorsi</surname><given-names>J.P.</given-names></name><name><surname>Edman</surname><given-names>J.D.</given-names></name><name><surname>Costero</surname><given-names>A.</given-names></name><name><surname>Kittayapong</surname><given-names>P.</given-names></name><name><surname>Clark</surname><given-names>G.G.</given-names></name><name><surname>Scott</surname><given-names>T.W.</given-names></name></person-group><article-title>Analysis of survival of young and old <italic>Aedes aegypti</italic> (Diptera: Culicidac) from Puerto Rico and Thailand</article-title><source>J. Med. Entomol.</source><year>2001</year><volume>38</volume><fpage>537</fpage><lpage>547</lpage><pub-id pub-id-type="doi">10.1603/0022-2585-38.4.537</pub-id><pub-id pub-id-type="pmid">11476334</pub-id></element-citation></ref><ref id="B5-viruses-11-00131"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lambrechts</surname><given-names>L.</given-names></name><name><surname>Scott</surname><given-names>T.W.</given-names></name><name><surname>Gubler</surname><given-names>D.J.</given-names></name></person-group><article-title>Consequences of the expanding global distribution of <italic>Aedes albopictus</italic> for dengue virus transmission</article-title><source>PLoS Negl. Trop. Dis.</source><year>2010</year><volume>4</volume><elocation-id>e646</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0000646</pub-id><pub-id pub-id-type="pmid">20520794</pub-id></element-citation></ref><ref id="B6-viruses-11-00131"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petitdemange</surname><given-names>C.</given-names></name><name><surname>Wauquier</surname><given-names>N.</given-names></name><name><surname>Vieillard</surname><given-names>V.</given-names></name></person-group><article-title>Control of immunopathology during chikungunya virus infection</article-title><source>J. Allergy Clin. Immunol.</source><year>2015</year><volume>135</volume><fpage>846</fpage><lpage>855</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2015.01.039</pub-id><?supplied-pmid 25843597?><pub-id pub-id-type="pmid">25843597</pub-id></element-citation></ref><ref id="B7-viruses-11-00131"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shepard</surname><given-names>D.S.</given-names></name><name><surname>Undurraga</surname><given-names>E.A.</given-names></name><name><surname>Halasa</surname><given-names>Y.A.</given-names></name><name><surname>Stanaway</surname><given-names>J.D.</given-names></name></person-group><article-title>The global economic burden of dengue: A systematic analysis</article-title><source>Lancet Infect. Dis.</source><year>2016</year><volume>16</volume><fpage>935</fpage><lpage>941</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(16)00146-8</pub-id><pub-id pub-id-type="pmid">27091092</pub-id></element-citation></ref><ref id="B8-viruses-11-00131"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laureti</surname><given-names>M.</given-names></name><name><surname>Narayanan</surname><given-names>D.</given-names></name><name><surname>Rodriguez-Andres</surname><given-names>J.</given-names></name><name><surname>Fazakerley</surname><given-names>J.K.</given-names></name><name><surname>Kedzierski</surname><given-names>L.</given-names></name></person-group><article-title>Flavivirus Receptors: Diversity, Identity and Cell Entry</article-title><source>Front. Immunol.</source><year>2018</year><volume>9</volume><fpage>2180</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2018.02180</pub-id><pub-id pub-id-type="pmid">30319635</pub-id></element-citation></ref><ref id="B9-viruses-11-00131"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Duijl-Richter</surname><given-names>M.K.</given-names></name><name><surname>Hoornweg</surname><given-names>T.E.</given-names></name><name><surname>Rodenhuis-Zybert</surname><given-names>I.A.</given-names></name><name><surname>Smit</surname><given-names>J.M.</given-names></name></person-group><article-title>Early Events in Chikungunya Virus Infection-From Virus Cell Binding to Membrane Fusion</article-title><source>Viruses</source><year>2015</year><volume>7</volume><fpage>3647</fpage><lpage>3674</lpage><pub-id pub-id-type="doi">10.3390/v7072792</pub-id><pub-id pub-id-type="pmid">26198242</pub-id></element-citation></ref><ref id="B10-viruses-11-00131"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palha</surname><given-names>N.</given-names></name><name><surname>Guivel-Benhassine</surname><given-names>F.</given-names></name><name><surname>Briolat</surname><given-names>V.</given-names></name><name><surname>Lutfalla</surname><given-names>G.</given-names></name><name><surname>Sourisseau</surname><given-names>M.</given-names></name><name><surname>Ellett</surname><given-names>F.</given-names></name><name><surname>Wang</surname><given-names>C.H.</given-names></name><name><surname>Lieschke</surname><given-names>G.J.</given-names></name><name><surname>Herbomel</surname><given-names>P.</given-names></name><name><surname>Schwartz</surname><given-names>O.</given-names></name><etal/></person-group><article-title>Real-time whole-body visualization of Chikungunya Virus infection and host interferon response in zebrafish</article-title><source>PLoS Pathog.</source><year>2013</year><volume>9</volume><elocation-id>e1003619</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1003619</pub-id><pub-id pub-id-type="pmid">24039582</pub-id></element-citation></ref><ref id="B11-viruses-11-00131"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>O.</given-names></name><name><surname>Albert</surname><given-names>M.L.</given-names></name></person-group><article-title>Biology and pathogenesis of chikungunya virus</article-title><source>Nat. Rev. Microbiol.</source><year>2010</year><volume>8</volume><fpage>491</fpage><lpage>500</lpage><pub-id pub-id-type="doi">10.1038/nrmicro2368</pub-id><?supplied-pmid 20551973?><pub-id pub-id-type="pmid">20551973</pub-id></element-citation></ref><ref id="B12-viruses-11-00131"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plante</surname><given-names>K.</given-names></name><name><surname>Wang</surname><given-names>E.</given-names></name><name><surname>Partidos</surname><given-names>C.D.</given-names></name><name><surname>Weger</surname><given-names>J.</given-names></name><name><surname>Gorchakov</surname><given-names>R.</given-names></name><name><surname>Tsetsarkin</surname><given-names>K.</given-names></name><name><surname>Borland</surname><given-names>E.M.</given-names></name><name><surname>Powers</surname><given-names>A.M.</given-names></name><name><surname>Seymour</surname><given-names>R.</given-names></name><name><surname>Stinchcomb</surname><given-names>D.T.</given-names></name><etal/></person-group><article-title>Novel chikungunya vaccine candidate with an IRES-based attenuation and host range alteration mechanism</article-title><source>PLoS Pathog.</source><year>2011</year><volume>7</volume><elocation-id>e1002142</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1002142</pub-id><pub-id pub-id-type="pmid">21829348</pub-id></element-citation></ref><ref id="B13-viruses-11-00131"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pingen</surname><given-names>M.</given-names></name><name><surname>Bryden</surname><given-names>S.R.</given-names></name><name><surname>Pondeville</surname><given-names>E.</given-names></name><name><surname>Schnettler</surname><given-names>E.</given-names></name><name><surname>Kohl</surname><given-names>A.</given-names></name><name><surname>Merits</surname><given-names>A.</given-names></name><name><surname>Fazakerley</surname><given-names>J.K.</given-names></name><name><surname>Graham</surname><given-names>G.J.</given-names></name><name><surname>McKimmie</surname><given-names>C.S.</given-names></name></person-group><article-title>Host Inflammatory Response to Mosquito Bites Enhances the Severity of Arbovirus Infection</article-title><source>Immunity</source><year>2016</year><volume>44</volume><fpage>1455</fpage><lpage>1469</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2016.06.002</pub-id><?supplied-pmid 27332734?><pub-id pub-id-type="pmid">27332734</pub-id></element-citation></ref><ref id="B14-viruses-11-00131"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pingen</surname><given-names>M.</given-names></name><name><surname>Schmid</surname><given-names>M.A.</given-names></name><name><surname>Harris</surname><given-names>E.</given-names></name><name><surname>McKimmie</surname><given-names>C.S.</given-names></name></person-group><article-title>Mosquito Biting Modulates Skin Response to Virus Infection</article-title><source>Trends Parasitol.</source><year>2017</year><volume>33</volume><fpage>645</fpage><lpage>657</lpage><pub-id pub-id-type="doi">10.1016/j.pt.2017.04.003</pub-id><?supplied-pmid 28495485?><pub-id pub-id-type="pmid">28495485</pub-id></element-citation></ref><ref id="B15-viruses-11-00131"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petitdemange</surname><given-names>C.</given-names></name><name><surname>Wauquier</surname><given-names>N.</given-names></name><name><surname>Rey</surname><given-names>J.</given-names></name><name><surname>Hervier</surname><given-names>B.</given-names></name><name><surname>Leroy</surname><given-names>E.</given-names></name><name><surname>Vieillard</surname><given-names>V.</given-names></name></person-group><article-title>Control of acute dengue virus infection by natural killer cells</article-title><source>Front. Immunol.</source><year>2014</year><volume>5</volume><fpage>209</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2014.00209</pub-id><?supplied-pmid 24860571?><pub-id pub-id-type="pmid">24860571</pub-id></element-citation></ref><ref id="B16-viruses-11-00131"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wikan</surname><given-names>N.</given-names></name><name><surname>Smith</surname><given-names>D.R.</given-names></name></person-group><article-title>Zika virus: History of a newly emerging arbovirus</article-title><source>Lancet Infect. Dis.</source><year>2016</year><volume>16</volume><fpage>e119</fpage><lpage>e126</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(16)30010-X</pub-id><pub-id pub-id-type="pmid">27282424</pub-id></element-citation></ref><ref id="B17-viruses-11-00131"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Auerswald</surname><given-names>H.</given-names></name><name><surname>Boussioux</surname><given-names>C.</given-names></name><name><surname>In</surname><given-names>S.</given-names></name><name><surname>Mao</surname><given-names>S.</given-names></name><name><surname>Ong</surname><given-names>S.</given-names></name><name><surname>Huy</surname><given-names>R.</given-names></name><name><surname>Leang</surname><given-names>R.</given-names></name><name><surname>Chan</surname><given-names>M.</given-names></name><name><surname>Duong</surname><given-names>V.</given-names></name><name><surname>Ly</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Broad and long-lasting immune protection against various Chikungunya genotypes demonstrated by participants in a cross-sectional study in a Cambodian rural community</article-title><source>Emerg. Microbes Infect.</source><year>2018</year><volume>7</volume><fpage>13</fpage><pub-id pub-id-type="doi">10.1038/s41426-017-0010-0</pub-id><?supplied-pmid 29410416?><pub-id pub-id-type="pmid">29410416</pub-id></element-citation></ref><ref id="B18-viruses-11-00131"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guzman</surname><given-names>M.G.</given-names></name><name><surname>Harris</surname><given-names>E.</given-names></name></person-group><article-title>Dengue</article-title><source>Lancet</source><year>2015</year><volume>385</volume><fpage>453</fpage><lpage>465</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(14)60572-9</pub-id><pub-id pub-id-type="pmid">25230594</pub-id></element-citation></ref><ref id="B19-viruses-11-00131"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katzelnick</surname><given-names>L.C.</given-names></name><name><surname>Gresh</surname><given-names>L.</given-names></name><name><surname>Halloran</surname><given-names>M.E.</given-names></name><name><surname>Mercado</surname><given-names>J.C.</given-names></name><name><surname>Kuan</surname><given-names>G.</given-names></name><name><surname>Gordon</surname><given-names>A.</given-names></name><name><surname>Balmaseda</surname><given-names>A.</given-names></name><name><surname>Harris</surname><given-names>E.</given-names></name></person-group><article-title>Antibody-dependent enhancement of severe dengue disease in humans</article-title><source>Science</source><year>2017</year><volume>358</volume><fpage>929</fpage><lpage>932</lpage><pub-id pub-id-type="doi">10.1126/science.aan6836</pub-id><pub-id pub-id-type="pmid">29097492</pub-id></element-citation></ref><ref id="B20-viruses-11-00131"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hammer</surname><given-names>Q.</given-names></name><name><surname>R&#x000fc;ckert</surname><given-names>T.</given-names></name><name><surname>Romagnani</surname><given-names>C.</given-names></name></person-group><article-title>Natural killer cell specificity for viral infections</article-title><source>Nat. Immunol.</source><year>2018</year><volume>19</volume><fpage>800</fpage><lpage>808</lpage><pub-id pub-id-type="doi">10.1038/s41590-018-0163-6</pub-id><pub-id pub-id-type="pmid">30026479</pub-id></element-citation></ref><ref id="B21-viruses-11-00131"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farber</surname><given-names>D.L.</given-names></name><name><surname>Yudanin</surname><given-names>N.A.</given-names></name><name><surname>Restifo</surname><given-names>N.P.</given-names></name></person-group><article-title>Human memory T cells: Generation, compartmentalization and homeostasis</article-title><source>Nat. Rev. Immunol.</source><year>2014</year><volume>14</volume><fpage>24</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1038/nri3567</pub-id><?supplied-pmid 24336101?><pub-id pub-id-type="pmid">24336101</pub-id></element-citation></ref><ref id="B22-viruses-11-00131"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Wallace</surname><given-names>D.L.</given-names></name><name><surname>de Lara</surname><given-names>C.M.</given-names></name><name><surname>Ghattas</surname><given-names>H.</given-names></name><name><surname>Asquith</surname><given-names>B.</given-names></name><name><surname>Worth</surname><given-names>A.</given-names></name><name><surname>Griffin</surname><given-names>G.E.</given-names></name><name><surname>Taylor</surname><given-names>G.P.</given-names></name><name><surname>Tough</surname><given-names>D.F.</given-names></name><name><surname>Beverley</surname><given-names>P.C.</given-names></name><etal/></person-group><article-title>In vivo kinetics of human natural killer cells: The effects of ageing and acute and chronic viral infection</article-title><source>Immunology</source><year>2007</year><volume>121</volume><fpage>258</fpage><lpage>265</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2567.2007.02573.x</pub-id><?supplied-pmid 17346281?><pub-id pub-id-type="pmid">17346281</pub-id></element-citation></ref><ref id="B23-viruses-11-00131"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orange</surname><given-names>J.S.</given-names></name></person-group><article-title>Natural killer cell deficiency</article-title><source>J. Allergy Clin. Immunol.</source><year>2013</year><volume>132</volume><fpage>515</fpage><lpage>525</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2013.07.020</pub-id><?supplied-pmid 23993353?><pub-id pub-id-type="pmid">23993353</pub-id></element-citation></ref><ref id="B24-viruses-11-00131"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mace</surname><given-names>E.M.</given-names></name><name><surname>Orange</surname><given-names>J.S.</given-names></name></person-group><article-title>Emerging insights into human health and NK cell biology from the study of NK cell deficiencies</article-title><source>Immunol. Rev.</source><year>2019</year><volume>287</volume><fpage>202</fpage><lpage>225</lpage><pub-id pub-id-type="doi">10.1111/imr.12725</pub-id><pub-id pub-id-type="pmid">30565241</pub-id></element-citation></ref><ref id="B25-viruses-11-00131"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vivier</surname><given-names>E.</given-names></name><name><surname>Tomasello</surname><given-names>E.</given-names></name><name><surname>Baratin</surname><given-names>M.</given-names></name><name><surname>Walzer</surname><given-names>T.</given-names></name><name><surname>Ugolini</surname><given-names>S.</given-names></name></person-group><article-title>Functions of natural killer cells</article-title><source>Nat. Immunol.</source><year>2008</year><volume>9</volume><fpage>503</fpage><lpage>510</lpage><pub-id pub-id-type="doi">10.1038/ni1582</pub-id><?supplied-pmid 18425107?><pub-id pub-id-type="pmid">18425107</pub-id></element-citation></ref><ref id="B26-viruses-11-00131"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jost</surname><given-names>S.</given-names></name><name><surname>Altfeld</surname><given-names>M.</given-names></name></person-group><article-title>Control of human viral infections by natural killer cells</article-title><source>Annu. Rev. Immunol.</source><year>2013</year><volume>31</volume><fpage>163</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.1146/annurev-immunol-032712-100001</pub-id><?supplied-pmid 23298212?><pub-id pub-id-type="pmid">23298212</pub-id></element-citation></ref><ref id="B27-viruses-11-00131"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bj&#x000f6;rkstr&#x000f6;m</surname><given-names>N.K.</given-names></name><name><surname>Ljunggren</surname><given-names>H.G.</given-names></name><name><surname>Micha&#x000eb;lsson</surname><given-names>J.</given-names></name></person-group><article-title>Emerging insights into natural killer cells in human peripheral tissues</article-title><source>Nat. Rev. Immunol.</source><year>2016</year><volume>16</volume><fpage>310</fpage><lpage>320</lpage><pub-id pub-id-type="doi">10.1038/nri.2016.34</pub-id><?supplied-pmid 27121652?><pub-id pub-id-type="pmid">27121652</pub-id></element-citation></ref><ref id="B28-viruses-11-00131"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Della Chiesa</surname><given-names>M.</given-names></name><name><surname>Sivori</surname><given-names>S.</given-names></name><name><surname>Carlomagno</surname><given-names>S.</given-names></name><name><surname>Moretta</surname><given-names>L.</given-names></name><name><surname>Moretta</surname><given-names>A.</given-names></name></person-group><article-title>Activating KIRs and NKG2C in Viral Infections: Toward NK Cell Memory?</article-title><source>Front. Immunol.</source><year>2015</year><volume>6</volume><fpage>573</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2015.00573</pub-id><pub-id pub-id-type="pmid">26617607</pub-id></element-citation></ref><ref id="B29-viruses-11-00131"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naiyer</surname><given-names>M.M.</given-names></name><name><surname>Cassidy</surname><given-names>S.A.</given-names></name><name><surname>Magri</surname><given-names>A.</given-names></name><name><surname>Cowton</surname><given-names>V.</given-names></name><name><surname>Chen</surname><given-names>K.</given-names></name><name><surname>Mansour</surname><given-names>S.</given-names></name><name><surname>Kranidioti</surname><given-names>H.</given-names></name><name><surname>Mbirbindi</surname><given-names>B.</given-names></name><name><surname>Rettman</surname><given-names>P.</given-names></name><name><surname>Harris</surname><given-names>S.</given-names></name><etal/></person-group><article-title>KIR2DS2 recognizes conserved peptides derived from viral helicases in the context of HLA-C</article-title><source>Sci. Immunol.</source><year>2017</year><volume>2</volume><fpage>eaal5296</fpage><pub-id pub-id-type="doi">10.1126/sciimmunol.aal5296</pub-id><?supplied-pmid 28916719?><pub-id pub-id-type="pmid">28916719</pub-id></element-citation></ref><ref id="B30-viruses-11-00131"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Long</surname><given-names>E.O.</given-names></name><name><surname>Kim</surname><given-names>H.S.</given-names></name><name><surname>Liu</surname><given-names>D.</given-names></name><name><surname>Peterson</surname><given-names>M.E.</given-names></name><name><surname>Rajagopalan</surname><given-names>S.</given-names></name></person-group><article-title>Controlling natural killer cell responses: Integration of signals for activation and inhibition</article-title><source>Annu. Rev. Immunol.</source><year>2013</year><volume>31</volume><fpage>227</fpage><lpage>258</lpage><pub-id pub-id-type="doi">10.1146/annurev-immunol-020711-075005</pub-id><pub-id pub-id-type="pmid">23516982</pub-id></element-citation></ref><ref id="B31-viruses-11-00131"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strauss-Albee</surname><given-names>D.M.</given-names></name><name><surname>Fukuyama</surname><given-names>J.</given-names></name><name><surname>Liang</surname><given-names>E.C.</given-names></name><name><surname>Yao</surname><given-names>Y.</given-names></name><name><surname>Jarrell</surname><given-names>J.A.</given-names></name><name><surname>Drake</surname><given-names>A.L.</given-names></name><name><surname>Kinuthia</surname><given-names>J.</given-names></name><name><surname>Montgomery</surname><given-names>R.R.</given-names></name><name><surname>John-Stewart</surname><given-names>G.</given-names></name><name><surname>Holmes</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Human NK cell repertoire diversity reflects immune experience and correlates with viral susceptibility</article-title><source>Sci. Transl. Med.</source><year>2015</year><volume>7</volume><fpage>297ra115</fpage><pub-id pub-id-type="doi">10.1126/scitranslmed.aac5722</pub-id></element-citation></ref><ref id="B32-viruses-11-00131"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kulkarni</surname><given-names>S.</given-names></name><name><surname>Martin</surname><given-names>M.P.</given-names></name><name><surname>Carrington</surname><given-names>M.</given-names></name></person-group><article-title>The Yin and Yang of HLA and KIR in human disease</article-title><source>Semin. Immunol.</source><year>2008</year><volume>20</volume><fpage>343</fpage><lpage>352</lpage><pub-id pub-id-type="doi">10.1016/j.smim.2008.06.003</pub-id><pub-id pub-id-type="pmid">18635379</pub-id></element-citation></ref><ref id="B33-viruses-11-00131"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petitdemange</surname><given-names>C.</given-names></name><name><surname>Wauquier</surname><given-names>N.</given-names></name><name><surname>Jacquet</surname><given-names>J.M.</given-names></name><name><surname>Theodorou</surname><given-names>I.</given-names></name><name><surname>Leroy</surname><given-names>E.</given-names></name><name><surname>Vieillard</surname><given-names>V.</given-names></name></person-group><article-title>Association of HLA class-I and inhibitory KIR genotypes in Gabonese patients infected by Chikungunya or Dengue type-2 viruses</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><elocation-id>e108798</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0108798</pub-id><pub-id pub-id-type="pmid">25264760</pub-id></element-citation></ref><ref id="B34-viruses-11-00131"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boudreau</surname><given-names>J.E.</given-names></name><name><surname>Hsu</surname><given-names>K.C.</given-names></name></person-group><article-title>Natural killer cell education in human health and disease</article-title><source>Curr. Opin. Immunol.</source><year>2018</year><volume>50</volume><fpage>102</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1016/j.coi.2017.11.003</pub-id><?supplied-pmid 29413815?><pub-id pub-id-type="pmid">29413815</pub-id></element-citation></ref><ref id="B35-viruses-11-00131"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuijpers</surname><given-names>T.W.</given-names></name><name><surname>Baars</surname><given-names>P.A.</given-names></name><name><surname>Dantin</surname><given-names>C.</given-names></name><name><surname>van den Burg</surname><given-names>M.</given-names></name><name><surname>van Lier</surname><given-names>R.A.</given-names></name><name><surname>Roosnek</surname><given-names>E.</given-names></name></person-group><article-title>Human NK cells can control CMV infection in the absence of T cells</article-title><source>Blood</source><year>2008</year><volume>112</volume><fpage>914</fpage><lpage>915</lpage><pub-id pub-id-type="doi">10.1182/blood-2008-05-157354</pub-id><?supplied-pmid 18650467?><pub-id pub-id-type="pmid">18650467</pub-id></element-citation></ref><ref id="B36-viruses-11-00131"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagner</surname><given-names>J.A.</given-names></name><name><surname>Fehniger</surname><given-names>T.A.</given-names></name></person-group><article-title>Human Adaptive Natural Killer Cells: Beyond NKG2C</article-title><source>Trends Immunol.</source><year>2016</year><volume>37</volume><fpage>351</fpage><lpage>353</lpage><pub-id pub-id-type="doi">10.1016/j.it.2016.05.001</pub-id><?supplied-pmid 27179621?><pub-id pub-id-type="pmid">27179621</pub-id></element-citation></ref><ref id="B37-viruses-11-00131"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malmberg</surname><given-names>K.J.</given-names></name><name><surname>Beziat</surname><given-names>V.</given-names></name><name><surname>Ljunggren</surname><given-names>H.G.</given-names></name></person-group><article-title>Spotlight on NKG2C and the human NK-cell response to CMV infection</article-title><source>Eur. J. Immunol.</source><year>2012</year><volume>42</volume><fpage>3141</fpage><lpage>3145</lpage><pub-id pub-id-type="doi">10.1002/eji.201243050</pub-id><pub-id pub-id-type="pmid">23255011</pub-id></element-citation></ref><ref id="B38-viruses-11-00131"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>L&#x000f3;pez-Botet</surname><given-names>M.</given-names></name><name><surname>Muntasell</surname><given-names>A.</given-names></name><name><surname>Vilches</surname><given-names>C.</given-names></name></person-group><article-title>The CD94/NKG2C+ NK-cell subset on the edge of innate and adaptive immunity to human cytomegalovirus infection</article-title><source>Semin. Immunol.</source><year>2014</year><volume>26</volume><fpage>145</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1016/j.smim.2014.03.002</pub-id><?supplied-pmid 24666761?><pub-id pub-id-type="pmid">24666761</pub-id></element-citation></ref><ref id="B39-viruses-11-00131"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>J.C.</given-names></name><name><surname>Beilke</surname><given-names>J.N.</given-names></name><name><surname>Lanier</surname><given-names>L.L.</given-names></name></person-group><article-title>Adaptive immune features of natural killer cells</article-title><source>Nature</source><year>2009</year><volume>457</volume><fpage>557</fpage><lpage>561</lpage><pub-id pub-id-type="doi">10.1038/nature07665</pub-id><pub-id pub-id-type="pmid">19136945</pub-id></element-citation></ref><ref id="B40-viruses-11-00131"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paust</surname><given-names>S.</given-names></name><name><surname>Gill</surname><given-names>H.S.</given-names></name><name><surname>Wang</surname><given-names>B.Z.</given-names></name><name><surname>Flynn</surname><given-names>M.P.</given-names></name><name><surname>Moseman</surname><given-names>E.A.</given-names></name><name><surname>Senman</surname><given-names>B.</given-names></name><name><surname>Szczepanik</surname><given-names>M.</given-names></name><name><surname>Telenti</surname><given-names>A.</given-names></name><name><surname>Askenase</surname><given-names>P.W.</given-names></name><name><surname>Compans</surname><given-names>R.W.</given-names></name><etal/></person-group><article-title>Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses</article-title><source>Nat. Immunol.</source><year>2010</year><volume>11</volume><fpage>1127</fpage><lpage>1135</lpage><pub-id pub-id-type="doi">10.1038/ni.1953</pub-id><pub-id pub-id-type="pmid">20972432</pub-id></element-citation></ref><ref id="B41-viruses-11-00131"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>N.M.</given-names></name><name><surname>O&#x02019;Sullivan</surname><given-names>T.E.</given-names></name><name><surname>Geary</surname><given-names>C.D.</given-names></name><name><surname>Karo</surname><given-names>J.M.</given-names></name><name><surname>Amezquita</surname><given-names>R.A.</given-names></name><name><surname>Joshi</surname><given-names>N.S.</given-names></name><name><surname>Kaech</surname><given-names>S.M.</given-names></name><name><surname>Sun</surname><given-names>J.C.</given-names></name></person-group><article-title>NK Cell Responses Redefine Immunological Memory</article-title><source>J. Immunol.</source><year>2016</year><volume>197</volume><fpage>2963</fpage><lpage>2970</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1600973</pub-id><?supplied-pmid 27824591?><pub-id pub-id-type="pmid">27824591</pub-id></element-citation></ref><ref id="B42-viruses-11-00131"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cerwenka</surname><given-names>A.</given-names></name><name><surname>Lanier</surname><given-names>L.L.</given-names></name></person-group><article-title>Natural killer cell memory in infection, inflammation and cancer</article-title><source>Nat. Rev. Immunol.</source><year>2016</year><volume>16</volume><fpage>112</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.1038/nri.2015.9</pub-id><?supplied-pmid 26806484?><pub-id pub-id-type="pmid">26806484</pub-id></element-citation></ref><ref id="B43-viruses-11-00131"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hotez</surname><given-names>P.J.</given-names></name><name><surname>Murray</surname><given-names>K.O.</given-names></name></person-group><article-title>Dengue, West Nile virus, chikungunya, Zika-and now Mayaro?</article-title><source>PLoS Negl. Trop. Dis.</source><year>2017</year><volume>11</volume><elocation-id>e0005462</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0005462</pub-id><?supplied-pmid 28859086?><pub-id pub-id-type="pmid">28859086</pub-id></element-citation></ref><ref id="B44-viruses-11-00131"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Acosta-Ampudia</surname><given-names>Y.</given-names></name><name><surname>Monsalve</surname><given-names>D.M.</given-names></name><name><surname>Rodr&#x000ed;guez</surname><given-names>Y.</given-names></name><name><surname>Pacheco</surname><given-names>Y.</given-names></name><name><surname>Anaya</surname><given-names>J.M.</given-names></name><name><surname>Ram&#x000ed;rez-Santana</surname><given-names>C.</given-names></name></person-group><article-title>Mayaro: An emerging viral threat?</article-title><source>Emerg. Microbes Infect.</source><year>2018</year><volume>7</volume><fpage>163</fpage><pub-id pub-id-type="doi">10.1038/s41426-018-0163-5</pub-id><?supplied-pmid 30254258?><pub-id pub-id-type="pmid">30254258</pub-id></element-citation></ref><ref id="B45-viruses-11-00131"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petitdemange</surname><given-names>C.</given-names></name><name><surname>Becquart</surname><given-names>P.</given-names></name><name><surname>Wauquier</surname><given-names>N.</given-names></name><name><surname>B&#x000e9;ziat</surname><given-names>V.</given-names></name><name><surname>Debr&#x000e9;</surname><given-names>P.</given-names></name><name><surname>Leroy</surname><given-names>E.M.</given-names></name><name><surname>Vieillard</surname><given-names>V.</given-names></name></person-group><article-title>Unconventional repertoire profile is imprinted during acute chikungunya infection for natural killer cells polarization toward cytotoxicity</article-title><source>PLoS Pathog.</source><year>2011</year><volume>7</volume><elocation-id>e1002268</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1002268</pub-id><?supplied-pmid 21966274?><pub-id pub-id-type="pmid">21966274</pub-id></element-citation></ref><ref id="B46-viruses-11-00131"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petitdemange</surname><given-names>C.</given-names></name><name><surname>Wauquier</surname><given-names>N.</given-names></name><name><surname>Devilliers</surname><given-names>H.</given-names></name><name><surname>Yssel</surname><given-names>H.</given-names></name><name><surname>Mombo</surname><given-names>I.</given-names></name><name><surname>Caron</surname><given-names>M.</given-names></name><name><surname>Nkogh&#x000e9;</surname><given-names>D.</given-names></name><name><surname>Debr&#x000e9;</surname><given-names>P.</given-names></name><name><surname>Leroy</surname><given-names>E.</given-names></name><name><surname>Vieillard</surname><given-names>V.</given-names></name></person-group><article-title>Longitudinal Analysis of Natural Killer Cells in Dengue Virus-Infected Patients in Comparison to Chikungunya and Chikungunya/Dengue Virus-Infected Patients</article-title><source>PLoS Negl. Trop. Dis.</source><year>2016</year><volume>10</volume><elocation-id>e0004499</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0004499</pub-id><?supplied-pmid 26938618?><pub-id pub-id-type="pmid">26938618</pub-id></element-citation></ref><ref id="B47-viruses-11-00131"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thanapati</surname><given-names>S.</given-names></name><name><surname>Das</surname><given-names>R.</given-names></name><name><surname>Tripathy</surname><given-names>A.S.</given-names></name></person-group><article-title>Phenotypic and functional analyses of NK and NKT-like populations during the early stages of chikungunya infection</article-title><source>Front. Microbiol.</source><year>2015</year><volume>6</volume><fpage>895</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2015.00895</pub-id><pub-id pub-id-type="pmid">26388848</pub-id></element-citation></ref><ref id="B48-viruses-11-00131"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fox</surname><given-names>J.M.</given-names></name><name><surname>Diamond</surname><given-names>M.S.</given-names></name></person-group><article-title>Immune-Mediated Protection and Pathogenesis of Chikungunya Virus</article-title><source>J. Immunol.</source><year>2016</year><volume>197</volume><fpage>4210</fpage><lpage>4218</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1601426</pub-id><pub-id pub-id-type="pmid">27864552</pub-id></element-citation></ref><ref id="B49-viruses-11-00131"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoarau</surname><given-names>J.J.</given-names></name><name><surname>Jaffar Bandjee</surname><given-names>M.C.</given-names></name><name><surname>Krejbich Trotot</surname><given-names>P.</given-names></name><name><surname>Das</surname><given-names>T.</given-names></name><name><surname>Li-Pat-Yuen</surname><given-names>G.</given-names></name><name><surname>Dassa</surname><given-names>B.</given-names></name><name><surname>Denizot</surname><given-names>M.</given-names></name><name><surname>Guichard</surname><given-names>E.</given-names></name><name><surname>Ribera</surname><given-names>A.</given-names></name><name><surname>Henni</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response</article-title><source>J. Immunol.</source><year>2010</year><volume>184</volume><fpage>5914</fpage><lpage>5927</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0900255</pub-id><pub-id pub-id-type="pmid">20404278</pub-id></element-citation></ref><ref id="B50-viruses-11-00131"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Della Chiesa</surname><given-names>M.</given-names></name><name><surname>Marcenaro</surname><given-names>E.</given-names></name><name><surname>Sivori</surname><given-names>S.</given-names></name><name><surname>Carlomagno</surname><given-names>S.</given-names></name><name><surname>Pesce</surname><given-names>S.</given-names></name><name><surname>Moretta</surname><given-names>A.</given-names></name></person-group><article-title>Human NK cell response to pathogens</article-title><source>Semin. Immunol.</source><year>2014</year><volume>26</volume><fpage>152</fpage><lpage>160</lpage><pub-id pub-id-type="doi">10.1016/j.smim.2014.02.001</pub-id><pub-id pub-id-type="pmid">24582551</pub-id></element-citation></ref><ref id="B51-viruses-11-00131"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gum&#x000e1;</surname><given-names>M.</given-names></name><name><surname>Angulo</surname><given-names>A.</given-names></name><name><surname>Vilches</surname><given-names>C.</given-names></name><name><surname>G&#x000f3;mez-Lozano</surname><given-names>N.</given-names></name><name><surname>Malats</surname><given-names>N.</given-names></name><name><surname>L&#x000f3;pez-Botet</surname><given-names>M.</given-names></name></person-group><article-title>Imprint of human cytomegalovirus infection on the NK cell receptor repertoire</article-title><source>Blood</source><year>2004</year><volume>104</volume><fpage>3664</fpage><lpage>3671</lpage><pub-id pub-id-type="doi">10.1182/blood-2004-05-2058</pub-id><?supplied-pmid 15304389?><pub-id pub-id-type="pmid">15304389</pub-id></element-citation></ref><ref id="B52-viruses-11-00131"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bj&#x000f6;rkstr&#x000f6;m</surname><given-names>N.K.</given-names></name><name><surname>Lindgren</surname><given-names>T.</given-names></name><name><surname>Stoltz</surname><given-names>M.</given-names></name><name><surname>Fauriat</surname><given-names>C.</given-names></name><name><surname>Braun</surname><given-names>M.</given-names></name><name><surname>Evander</surname><given-names>M.</given-names></name><name><surname>Micha&#x000eb;lsson</surname><given-names>J.</given-names></name><name><surname>Malmberg</surname><given-names>K.J.</given-names></name><name><surname>Klingstr&#x000f6;m</surname><given-names>J.</given-names></name><name><surname>Ahlm</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus</article-title><source>J. Exp. Med.</source><year>2011</year><volume>208</volume><fpage>13</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1084/jem.20100762</pub-id><?supplied-pmid 21173105?><pub-id pub-id-type="pmid">21173105</pub-id></element-citation></ref><ref id="B53-viruses-11-00131"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliviero</surname><given-names>B.</given-names></name><name><surname>Varchetta</surname><given-names>S.</given-names></name><name><surname>Paudice</surname><given-names>E.</given-names></name><name><surname>Michelone</surname><given-names>G.</given-names></name><name><surname>Zaramella</surname><given-names>M.</given-names></name><name><surname>Mavilio</surname><given-names>D.</given-names></name><name><surname>De Filippi</surname><given-names>F.</given-names></name><name><surname>Bruno</surname><given-names>S.</given-names></name><name><surname>Mondelli</surname><given-names>M.U.</given-names></name></person-group><article-title>Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections</article-title><source>Gastroenterology</source><year>2009</year><volume>137</volume><fpage>1151</fpage><lpage>1160</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2009.05.047</pub-id><?supplied-pmid 19470388?><pub-id pub-id-type="pmid">19470388</pub-id></element-citation></ref><ref id="B54-viruses-11-00131"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>B&#x000e9;ziat</surname><given-names>V.</given-names></name><name><surname>Dalgard</surname><given-names>O.</given-names></name><name><surname>Asselah</surname><given-names>T.</given-names></name><name><surname>Halfon</surname><given-names>P.</given-names></name><name><surname>Bedossa</surname><given-names>P.</given-names></name><name><surname>Boudifa</surname><given-names>A.</given-names></name><name><surname>Hervier</surname><given-names>B.</given-names></name><name><surname>Theodorou</surname><given-names>I.</given-names></name><name><surname>Martinot</surname><given-names>M.</given-names></name><name><surname>Debr&#x000e9;</surname><given-names>P.</given-names></name><etal/></person-group><article-title>CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients</article-title><source>Eur. J. Immunol.</source><year>2012</year><volume>42</volume><fpage>447</fpage><lpage>457</lpage><pub-id pub-id-type="doi">10.1002/eji.201141826</pub-id><?supplied-pmid 22105371?><pub-id pub-id-type="pmid">22105371</pub-id></element-citation></ref><ref id="B55-viruses-11-00131"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>R&#x000f6;lle</surname><given-names>A.</given-names></name><name><surname>Brodin</surname><given-names>P.</given-names></name></person-group><article-title>Immune Adaptation to Environmental Influence: The Case of NK Cells and HCMV</article-title><source>Trends Immunol.</source><year>2016</year><volume>37</volume><fpage>233</fpage><lpage>243</lpage><pub-id pub-id-type="doi">10.1016/j.it.2016.01.005</pub-id><?supplied-pmid 26869205?><pub-id pub-id-type="pmid">26869205</pub-id></element-citation></ref><ref id="B56-viruses-11-00131"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>R&#x000f6;lle</surname><given-names>A.</given-names></name><name><surname>Pollmann</surname><given-names>J.</given-names></name><name><surname>Ewen</surname><given-names>E.M.</given-names></name><name><surname>Le</surname><given-names>V.T.</given-names></name><name><surname>Halenius</surname><given-names>A.</given-names></name><name><surname>Hengel</surname><given-names>H.</given-names></name><name><surname>Cerwenka</surname><given-names>A.</given-names></name></person-group><article-title>IL-12-producing monocytes and HLA-E control HCMV-driven NKG2C+ NK cell expansion</article-title><source>J. Clin. Investig.</source><year>2014</year><volume>124</volume><fpage>5305</fpage><lpage>5316</lpage><pub-id pub-id-type="doi">10.1172/JCI77440</pub-id><pub-id pub-id-type="pmid">25384219</pub-id></element-citation></ref><ref id="B57-viruses-11-00131"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braun</surname><given-names>M.</given-names></name><name><surname>Bj&#x000f6;rkstr&#x000f6;m</surname><given-names>N.K.</given-names></name><name><surname>Gupta</surname><given-names>S.</given-names></name><name><surname>Sundstr&#x000f6;m</surname><given-names>K.</given-names></name><name><surname>Ahlm</surname><given-names>C.</given-names></name><name><surname>Klingstr&#x000f6;m</surname><given-names>J.</given-names></name><name><surname>Ljunggren</surname><given-names>H.G.</given-names></name></person-group><article-title>NK cell activation in human hantavirus infection explained by virus-induced IL-15/IL15R&#x003b1; expression</article-title><source>PLoS Pathog.</source><year>2014</year><volume>10</volume><elocation-id>e1004521</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1004521</pub-id><pub-id pub-id-type="pmid">25412359</pub-id></element-citation></ref><ref id="B58-viruses-11-00131"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>R&#x000f6;lle</surname><given-names>A.</given-names></name><name><surname>Meyer</surname><given-names>M.</given-names></name><name><surname>Calderazzo</surname><given-names>S.</given-names></name><name><surname>J&#x000e4;ger</surname><given-names>D.</given-names></name><name><surname>Momburg</surname><given-names>F.</given-names></name></person-group><article-title>Distinct HLA-E Peptide Complexes Modify Antibody-Driven Effector Functions of Adaptive NK Cells</article-title><source>Cell Rep.</source><year>2018</year><volume>24</volume><fpage>1967</fpage><lpage>1976</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2018.07.069</pub-id><pub-id pub-id-type="pmid">30134159</pub-id></element-citation></ref><ref id="B59-viruses-11-00131"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lam</surname><given-names>V.C.</given-names></name><name><surname>Lanier</surname><given-names>L.L.</given-names></name></person-group><article-title>NK cells in host responses to viral infections</article-title><source>Curr. Opin. Immunol.</source><year>2017</year><volume>44</volume><fpage>43</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1016/j.coi.2016.11.003</pub-id><pub-id pub-id-type="pmid">27984782</pub-id></element-citation></ref><ref id="B60-viruses-11-00131"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>J.C.</given-names></name><name><surname>Lanier</surname><given-names>L.L.</given-names></name></person-group><article-title>Is There Natural Killer Cell Memory and Can It Be Harnessed by Vaccination? NK Cell Memory and Immunization Strategies against Infectious Diseases and Cancer</article-title><source>Cold Spring Harb. Perspect. Biol.</source><year>2018</year><volume>1010</volume><fpage>a029538</fpage><pub-id pub-id-type="doi">10.1101/cshperspect.a029538</pub-id></element-citation></ref><ref id="B61-viruses-11-00131"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teo</surname><given-names>T.H.</given-names></name><name><surname>Her</surname><given-names>Z.</given-names></name><name><surname>Tan</surname><given-names>J.J.</given-names></name><name><surname>Lum</surname><given-names>F.M.</given-names></name><name><surname>Lee</surname><given-names>W.W.</given-names></name><name><surname>Chan</surname><given-names>Y.H.</given-names></name><name><surname>Ong</surname><given-names>R.Y.</given-names></name><name><surname>Kam</surname><given-names>Y.W.</given-names></name><name><surname>Leparc-Goffart</surname><given-names>I.</given-names></name><name><surname>Gallian</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Caribbean and La R&#x000e9;union Chikungunya Virus Isolates Differ in Their Capacity To Induce Proinflammatory Th1 and NK Cell Responses and Acute Joint Pathology</article-title><source>J. Virol.</source><year>2015</year><volume>89</volume><fpage>7955</fpage><lpage>7969</lpage><pub-id pub-id-type="doi">10.1128/JVI.00909-15</pub-id><pub-id pub-id-type="pmid">25995257</pub-id></element-citation></ref><ref id="B62-viruses-11-00131"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huss</surname><given-names>R.S.</given-names></name><name><surname>Huddleston</surname><given-names>J.I.</given-names></name><name><surname>Goodman</surname><given-names>S.B.</given-names></name><name><surname>Butcher</surname><given-names>E.C.</given-names></name><name><surname>Zabel</surname><given-names>B.A.</given-names></name></person-group><article-title>Synovial tissue-infiltrating natural killer cells in osteoarthritis and periprosthetic inflammation</article-title><source>Arthritis Rheum.</source><year>2010</year><volume>62</volume><fpage>3799</fpage><lpage>3805</lpage><pub-id pub-id-type="doi">10.1002/art.27751</pub-id><?supplied-pmid 20848566?><pub-id pub-id-type="pmid">20848566</pub-id></element-citation></ref><ref id="B63-viruses-11-00131"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaime</surname><given-names>P.</given-names></name><name><surname>Garc&#x000ed;a-Guerrero</surname><given-names>N.</given-names></name><name><surname>Estella</surname><given-names>R.</given-names></name><name><surname>Pardo</surname><given-names>J.</given-names></name><name><surname>Garc&#x000ed;a-&#x000c1;lvarez</surname><given-names>F.</given-names></name><name><surname>Martinez-Lostao</surname><given-names>L.</given-names></name></person-group><article-title>CD56<sup>+</sup>/CD16<sup>&#x02212;</sup> Natural Killer cells expressing the inflammatory protease granzyme A are enriched in synovial fluid from patients with osteoarthritis</article-title><source>Osteoarthr. Cartil.</source><year>2017</year><volume>25</volume><fpage>1708</fpage><lpage>1718</lpage><pub-id pub-id-type="doi">10.1016/j.joca.2017.06.007</pub-id><?supplied-pmid 28668542?><pub-id pub-id-type="pmid">28668542</pub-id></element-citation></ref><ref id="B64-viruses-11-00131"><label>64.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Strode</surname><given-names>G.K.</given-names></name></person-group><source>Yellow Fever</source><publisher-name>McGraw-Hill</publisher-name><publisher-loc>New York, NY, USA</publisher-loc><year>1951</year></element-citation></ref><ref id="B65-viruses-11-00131"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname><given-names>X.Y.</given-names></name><name><surname>Briese</surname><given-names>T.</given-names></name><name><surname>Jordan</surname><given-names>I.</given-names></name><name><surname>Rambaut</surname><given-names>A.</given-names></name><name><surname>Chi</surname><given-names>H.C.</given-names></name><name><surname>Mackenzie</surname><given-names>J.S.</given-names></name><name><surname>Hall</surname><given-names>R.A.</given-names></name><name><surname>Scherret</surname><given-names>J.</given-names></name><name><surname>Lipkin</surname><given-names>W.I.</given-names></name></person-group><article-title>Genetic analysis of West Nile New York 1999 encephalitis virus</article-title><source>Lancet</source><year>1999</year><volume>354</volume><fpage>1971</fpage><lpage>1972</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(99)05384-2</pub-id><pub-id pub-id-type="pmid">10622305</pub-id></element-citation></ref><ref id="B66-viruses-11-00131"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ngono</surname><given-names>A.E.</given-names></name><name><surname>Shresta</surname><given-names>S.</given-names></name></person-group><article-title>Immune Response to Dengue and Zika</article-title><source>Annu. Rev. Immunol.</source><year>2018</year><volume>36</volume><fpage>279</fpage><lpage>308</lpage><pub-id pub-id-type="doi">10.1146/annurev-immunol-042617-053142</pub-id><pub-id pub-id-type="pmid">29345964</pub-id></element-citation></ref><ref id="B67-viruses-11-00131"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Becquart</surname><given-names>P.</given-names></name><name><surname>Wauquier</surname><given-names>N.</given-names></name><name><surname>Nkoghe</surname><given-names>D.</given-names></name><name><surname>Ndjoyi-Mbiguino</surname><given-names>A.</given-names></name><name><surname>Padilla</surname><given-names>C.</given-names></name><name><surname>Souris</surname><given-names>M.</given-names></name><name><surname>Leroy</surname><given-names>E.M.</given-names></name></person-group><article-title>Acute dengue virus 2 infection in Gabonese patients is associated with an early innate immune response, including strong interferon alpha production</article-title><source>BMC Infect. Dis.</source><year>2010</year><volume>10</volume><elocation-id>356</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2334-10-356</pub-id><pub-id pub-id-type="pmid">21167041</pub-id></element-citation></ref><ref id="B68-viruses-11-00131"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>P.</given-names></name><name><surname>Garc&#x000ed;a</surname><given-names>J.</given-names></name><name><surname>Comach</surname><given-names>G.</given-names></name><name><surname>Vahey</surname><given-names>M.T.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Forshey</surname><given-names>B.M.</given-names></name><name><surname>Morrison</surname><given-names>A.C.</given-names></name><name><surname>Sierra</surname><given-names>G.</given-names></name><name><surname>Bazan</surname><given-names>I.</given-names></name><name><surname>Rocha</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Sequential waves of gene expression in patients with clinically defined dengue illnesses reveal subtle disease phases and predict disease severity</article-title><source>PLoS Negl. Trop. Dis.</source><year>2013</year><volume>7</volume><elocation-id>e2298</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0002298</pub-id><pub-id pub-id-type="pmid">23875036</pub-id></element-citation></ref><ref id="B69-viruses-11-00131"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biron</surname><given-names>C.A.</given-names></name><name><surname>Nguyen</surname><given-names>K.B.</given-names></name><name><surname>Pien</surname><given-names>G.C.</given-names></name><name><surname>Cousens</surname><given-names>L.P.</given-names></name><name><surname>Salazar-Mather</surname><given-names>T.P.</given-names></name></person-group><article-title>Natural killer cells in antiviral defense: Function and regulation by innate cytokines</article-title><source>Annu. Rev. Immunol.</source><year>1999</year><volume>17</volume><fpage>189</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.1146/annurev.immunol.17.1.189</pub-id><pub-id pub-id-type="pmid">10358757</pub-id></element-citation></ref><ref id="B70-viruses-11-00131"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>V.V.</given-names></name><name><surname>Ye</surname><given-names>W.</given-names></name><name><surname>Chen</surname><given-names>Q.</given-names></name><name><surname>Teixeira</surname><given-names>M.M.</given-names></name><name><surname>Preiser</surname><given-names>P.</given-names></name><name><surname>Ooi</surname><given-names>E.E.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name></person-group><article-title>Dengue Virus-Infected Dendritic Cells but Not Monocytes, Activate Natural Killer Cells through a Contact-Dependent Mechanism Involving Adhesion Molecules</article-title><source>mBio</source><year>2017</year><volume>8</volume><fpage>e00741-17</fpage><pub-id pub-id-type="doi">10.1128/mBio.00741-17</pub-id><pub-id pub-id-type="pmid">28765218</pub-id></element-citation></ref><ref id="B71-viruses-11-00131"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keawvichit</surname><given-names>R.</given-names></name><name><surname>Khowawisetsut</surname><given-names>L.</given-names></name><name><surname>Lertjuthaporn</surname><given-names>S.</given-names></name><name><surname>Tangnararatchakit</surname><given-names>K.</given-names></name><name><surname>Apiwattanakul</surname><given-names>N.</given-names></name><name><surname>Yoksan</surname><given-names>S.</given-names></name><name><surname>Chuansumrit</surname><given-names>A.</given-names></name><name><surname>Chokephaibulkit</surname><given-names>K.</given-names></name><name><surname>Ansari</surname><given-names>A.A.</given-names></name><name><surname>Onlamoon</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Differences in activation and tissue homing markers of natural killer cell subsets during acute dengue infection</article-title><source>Immunology</source><year>2018</year><volume>153</volume><fpage>455</fpage><lpage>465</lpage><pub-id pub-id-type="doi">10.1111/imm.12858</pub-id><pub-id pub-id-type="pmid">29105052</pub-id></element-citation></ref><ref id="B72-viruses-11-00131"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsieh</surname><given-names>M.F.</given-names></name><name><surname>Lai</surname><given-names>S.L.</given-names></name><name><surname>Chen</surname><given-names>J.P.</given-names></name><name><surname>Sung</surname><given-names>J.M.</given-names></name><name><surname>Lin</surname><given-names>Y.L.</given-names></name><name><surname>Wu-Hsieh</surname><given-names>B.A.</given-names></name><name><surname>Gerard</surname><given-names>C.</given-names></name><name><surname>Luster</surname><given-names>A.</given-names></name><name><surname>Liao</surname><given-names>F.</given-names></name></person-group><article-title>Both CXCR3 and CXCL10/IFN-inducible protein 10 are required for resistance to primary infection by dengue virus</article-title><source>J. Immunol.</source><year>2006</year><volume>177</volume><fpage>1855</fpage><lpage>1863</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.177.3.1855</pub-id><?supplied-pmid 16849497?><pub-id pub-id-type="pmid">16849497</pub-id></element-citation></ref><ref id="B73-viruses-11-00131"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azeredo</surname><given-names>E.L.</given-names></name><name><surname>De Oliveira-Pinto</surname><given-names>L.M.</given-names></name><name><surname>Zagne</surname><given-names>S.M.</given-names></name><name><surname>Cerqueira</surname><given-names>D.I.</given-names></name><name><surname>Nogueira</surname><given-names>R.M.</given-names></name><name><surname>Kubelka</surname><given-names>C.F.</given-names></name></person-group><article-title>NK cells, displaying early activation, cytotoxicity and adhesion molecules, are associated with mild dengue disease</article-title><source>Clin. Exp. Immunol.</source><year>2006</year><volume>143</volume><fpage>345</fpage><lpage>356</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2249.2006.02996.x</pub-id><?supplied-pmid 16412060?><pub-id pub-id-type="pmid">16412060</pub-id></element-citation></ref><ref id="B74-viruses-11-00131"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>S.</given-names></name><name><surname>Pichyangkul</surname><given-names>S.</given-names></name><name><surname>Vaughn</surname><given-names>D.W.</given-names></name><name><surname>Kalayanarooj</surname><given-names>S.</given-names></name><name><surname>Nimmannitya</surname><given-names>S.</given-names></name><name><surname>Nisalak</surname><given-names>A.</given-names></name><name><surname>Kurane</surname><given-names>I.</given-names></name><name><surname>Rothman</surname><given-names>A.L.</given-names></name><name><surname>Ennis</surname><given-names>F.A.</given-names></name></person-group><article-title>Early CD69 expression on peripheral blood lymphocytes from children with dengue hemorrhagic fever</article-title><source>J. Infect. Dis.</source><year>1999</year><volume>180</volume><fpage>1429</fpage><lpage>1435</lpage><pub-id pub-id-type="doi">10.1086/315072</pub-id><?supplied-pmid 10515800?><pub-id pub-id-type="pmid">10515800</pub-id></element-citation></ref><ref id="B75-viruses-11-00131"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>Y.</given-names></name><name><surname>Strauss-Albeen</surname><given-names>D.M.</given-names></name><name><surname>Zhou</surname><given-names>J.Q.</given-names></name><name><surname>Malawista</surname><given-names>A.</given-names></name><name><surname>Garcia</surname><given-names>M.N.</given-names></name><name><surname>Murray</surname><given-names>K.O.</given-names></name><name><surname>Blish</surname><given-names>C.A.</given-names></name><name><surname>Montgomery</surname><given-names>R.R.</given-names></name></person-group><article-title>The natural killer cell response to West Nile virus in young and old individuals with or without a prior history of infection</article-title><source>PLoS ONE</source><year>2017</year><volume>12</volume><elocation-id>e0172625</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0172625</pub-id><?supplied-pmid 28235099?><pub-id pub-id-type="pmid">28235099</pub-id></element-citation></ref><ref id="B76-viruses-11-00131"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>B&#x000e9;ziat</surname><given-names>V.</given-names></name><name><surname>Sleiman</surname><given-names>M.</given-names></name><name><surname>Goodridge</surname><given-names>J.P.</given-names></name><name><surname>Kaarb&#x000f8;</surname><given-names>M.</given-names></name><name><surname>Liu</surname><given-names>L.L.</given-names></name><name><surname>Rollag</surname><given-names>H.</given-names></name><name><surname>Ljunggren</surname><given-names>H.G.</given-names></name><name><surname>Zimmer</surname><given-names>J.</given-names></name><name><surname>Malmberg</surname><given-names>K.J.</given-names></name></person-group><article-title>Polyclonal Expansion of NKG2C(+) NK Cells in TAP-Deficient Patients</article-title><source>Front. Immunol.</source><year>2015</year><volume>6</volume><fpage>507</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2015.00507</pub-id><?supplied-pmid 26500647?><pub-id pub-id-type="pmid">26500647</pub-id></element-citation></ref><ref id="B77-viruses-11-00131"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neves</surname><given-names>P.C.</given-names></name><name><surname>Matos</surname><given-names>D.C.</given-names></name><name><surname>Marcovistz</surname><given-names>R.</given-names></name><name><surname>Galler</surname><given-names>R.</given-names></name></person-group><article-title>TLR expression and NK cell activation after human yellow fever vaccination</article-title><source>Vaccine</source><year>2009</year><volume>27</volume><fpage>5543</fpage><lpage>5549</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2009.07.028</pub-id><?supplied-pmid 19647065?><pub-id pub-id-type="pmid">19647065</pub-id></element-citation></ref><ref id="B78-viruses-11-00131"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marquardt</surname><given-names>N.</given-names></name><name><surname>Ivarsson</surname><given-names>M.A.</given-names></name><name><surname>Blom</surname><given-names>K.</given-names></name><name><surname>Gonzalez</surname><given-names>V.D.</given-names></name><name><surname>Braun</surname><given-names>M.</given-names></name><name><surname>Falconer</surname><given-names>K.</given-names></name><name><surname>Gustafsson</surname><given-names>R.</given-names></name><name><surname>Fogdell-Hahn</surname><given-names>A.</given-names></name><name><surname>Sandberg</surname><given-names>J.K.</given-names></name><name><surname>Micha&#x000eb;lsson</surname><given-names>J.</given-names></name></person-group><article-title>The Human NK Cell Response to Yellow Fever Virus 17D Is Primarily Governed by NK Cell Differentiation Independently of NK Cell Education</article-title><source>J. Immunol.</source><year>2015</year><volume>195</volume><fpage>3262</fpage><lpage>3272</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1401811</pub-id><?supplied-pmid 26283480?><pub-id pub-id-type="pmid">26283480</pub-id></element-citation></ref><ref id="B79-viruses-11-00131"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beltrame</surname><given-names>L.M.</given-names></name><name><surname>Sell</surname><given-names>A.M.</given-names></name><name><surname>Moliterno</surname><given-names>R.A.</given-names></name><name><surname>Clementino</surname><given-names>S.L.</given-names></name><name><surname>Cardozo</surname><given-names>D.M.</given-names></name><name><surname>Dalalio</surname><given-names>M.M.</given-names></name><name><surname>Fonzar</surname><given-names>U.J.</given-names></name><name><surname>Visentainer</surname><given-names>J.E.</given-names></name></person-group><article-title>Influence of KIR genes and their HLA ligands in susceptibility to dengue in a population from southern Brazil</article-title><source>Tissue Antigens</source><year>2013</year><volume>82</volume><fpage>397</fpage><lpage>404</lpage><pub-id pub-id-type="doi">10.1111/tan.12256</pub-id><?supplied-pmid 24498996?><pub-id pub-id-type="pmid">24498996</pub-id></element-citation></ref><ref id="B80-viruses-11-00131"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alagarasu</surname><given-names>K.</given-names></name><name><surname>Bachal</surname><given-names>R.V.</given-names></name><name><surname>Shah</surname><given-names>P.S.</given-names></name><name><surname>Cecilia</surname><given-names>D.</given-names></name></person-group><article-title>Profile of killer cell immunoglobulin-like receptor and its human leucocyte antigen ligands in dengue-infected patients from Western India</article-title><source>Int. J. Immunogenet.</source><year>2015</year><volume>42</volume><fpage>432</fpage><lpage>438</lpage><pub-id pub-id-type="doi">10.1111/iji.12231</pub-id><pub-id pub-id-type="pmid">26385514</pub-id></element-citation></ref><ref id="B81-viruses-11-00131"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alter</surname><given-names>G.</given-names></name><name><surname>Heckerman</surname><given-names>D.</given-names></name><name><surname>Schneidewind</surname><given-names>A.</given-names></name><name><surname>Fadda</surname><given-names>L.</given-names></name><name><surname>Kadie</surname><given-names>C.M.</given-names></name><name><surname>Carlson</surname><given-names>J.M.</given-names></name><name><surname>Oniangue-Ndza</surname><given-names>C.</given-names></name><name><surname>Martin</surname><given-names>M.</given-names></name><name><surname>Li</surname><given-names>B.</given-names></name><name><surname>Khakoo</surname><given-names>S.I.</given-names></name><etal/></person-group><article-title>HIV-1 adaptation to NK-cell-mediated immune pressure</article-title><source>Nature</source><year>2011</year><volume>476</volume><fpage>96</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1038/nature10237</pub-id><pub-id pub-id-type="pmid">21814282</pub-id></element-citation></ref><ref id="B82-viruses-11-00131"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Townsley</surname><given-names>E.</given-names></name><name><surname>O&#x02019;Connor</surname><given-names>G.</given-names></name><name><surname>Cosgrove</surname><given-names>C.</given-names></name><name><surname>Woda</surname><given-names>M.</given-names></name><name><surname>Co</surname><given-names>M.</given-names></name><name><surname>Thomas</surname><given-names>S.J.</given-names></name><name><surname>Kalayanarooj</surname><given-names>S.</given-names></name><name><surname>Yoon</surname><given-names>I.K.</given-names></name><name><surname>Nisalak</surname><given-names>A.</given-names></name><name><surname>Srikiatkhachorn</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Interaction of a dengue virus NS1-derived peptide with the inhibitory receptor KIR3DL1 on natural killer cells</article-title><source>Clin. Exp. Immunol.</source><year>2016</year><volume>183</volume><fpage>419</fpage><lpage>430</lpage><pub-id pub-id-type="doi">10.1111/cei.12722</pub-id><?supplied-pmid 26439909?><pub-id pub-id-type="pmid">26439909</pub-id></element-citation></ref><ref id="B83-viruses-11-00131"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blom</surname><given-names>K.</given-names></name><name><surname>Braun</surname><given-names>M.</given-names></name><name><surname>Pakalniene</surname><given-names>J.</given-names></name><name><surname>Lunemann</surname><given-names>S.</given-names></name><name><surname>Enqvist</surname><given-names>M.</given-names></name><name><surname>Dailidyte</surname><given-names>L.</given-names></name><name><surname>Schaffer</surname><given-names>M.</given-names></name><name><surname>Lindquist</surname><given-names>L.</given-names></name><name><surname>Mickiene</surname><given-names>A.</given-names></name><name><surname>Micha&#x000eb;lsson</surname><given-names>J.</given-names></name><etal/></person-group><article-title>NK Cell Responses to Human Tick-Borne Encephalitis Virus Infection</article-title><source>J. Immunol.</source><year>2016</year><volume>197</volume><fpage>2762</fpage><lpage>2771</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1600950</pub-id><?supplied-pmid 27543616?><pub-id pub-id-type="pmid">27543616</pub-id></element-citation></ref><ref id="B84-viruses-11-00131"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meresse</surname><given-names>B.</given-names></name><name><surname>Curran</surname><given-names>S.A.</given-names></name><name><surname>Ciszewski</surname><given-names>C.</given-names></name><name><surname>Orbelyan</surname><given-names>G.</given-names></name><name><surname>Setty</surname><given-names>M.</given-names></name><name><surname>Bhagat</surname><given-names>G.</given-names></name><name><surname>Lee</surname><given-names>L.</given-names></name><name><surname>Tretiakova</surname><given-names>M.</given-names></name><name><surname>Semrad</surname><given-names>C.</given-names></name><name><surname>Kistner</surname><given-names>E.</given-names></name><etal/></person-group><article-title>Reprogramming of CTLs into natural killer-like cells in celiac disease</article-title><source>J. Exp. Med.</source><year>2006</year><volume>203</volume><fpage>1343</fpage><lpage>1355</lpage><pub-id pub-id-type="doi">10.1084/jem.20060028</pub-id><?supplied-pmid 16682498?><pub-id pub-id-type="pmid">16682498</pub-id></element-citation></ref><ref id="B85-viruses-11-00131"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vitale</surname><given-names>M.</given-names></name><name><surname>Bottino</surname><given-names>C.</given-names></name><name><surname>Sivori</surname><given-names>S.</given-names></name><name><surname>Sanseverino</surname><given-names>L.</given-names></name><name><surname>Castriconi</surname><given-names>R.</given-names></name><name><surname>Marcenaro</surname><given-names>E.</given-names></name><name><surname>Augugliaro</surname><given-names>R.</given-names></name><name><surname>Moretta</surname><given-names>L.</given-names></name><name><surname>Moretta</surname><given-names>A.</given-names></name></person-group><article-title>NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis</article-title><source>J. Exp. Med.</source><year>1998</year><volume>187</volume><fpage>2065</fpage><lpage>2072</lpage><pub-id pub-id-type="doi">10.1084/jem.187.12.2065</pub-id><?supplied-pmid 9625766?><pub-id pub-id-type="pmid">9625766</pub-id></element-citation></ref><ref id="B86-viruses-11-00131"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baychelier</surname><given-names>F.</given-names></name><name><surname>Sennepin</surname><given-names>A.</given-names></name><name><surname>Ermonval</surname><given-names>M.</given-names></name><name><surname>Dorgham</surname><given-names>K.</given-names></name><name><surname>Debr&#x000e9;</surname><given-names>P.</given-names></name><name><surname>Vieillard</surname><given-names>V.</given-names></name></person-group><article-title>Identification of a cellular ligand for the natural cytotoxicity receptor NKp44</article-title><source>Blood</source><year>2013</year><volume>122</volume><fpage>2935</fpage><lpage>2942</lpage><pub-id pub-id-type="doi">10.1182/blood-2013-03-489054</pub-id><?supplied-pmid 23958951?><pub-id pub-id-type="pmid">23958951</pub-id></element-citation></ref><ref id="B87-viruses-11-00131"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hershkovitz</surname><given-names>O.</given-names></name><name><surname>Rosental</surname><given-names>B.</given-names></name><name><surname>Rosenberg</surname><given-names>L.A.</given-names></name><name><surname>Navarro-Sanchez</surname><given-names>M.E.</given-names></name><name><surname>Jivov</surname><given-names>S.</given-names></name><name><surname>Zilka</surname><given-names>A.</given-names></name><name><surname>Gershoni-Yahalom</surname><given-names>O.</given-names></name><name><surname>Brient-Litzler</surname><given-names>E.</given-names></name><name><surname>Bedouelle</surname><given-names>H.</given-names></name><name><surname>Ho</surname><given-names>J.W.</given-names></name><etal/></person-group><article-title>NKp44 receptor mediates interaction of the envelope glycoproteins from the West Nile and dengue viruses with NK cells</article-title><source>J. Immunol.</source><year>2009</year><volume>183</volume><fpage>2610</fpage><lpage>2621</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0802806</pub-id><?supplied-pmid 19635919?><pub-id pub-id-type="pmid">19635919</pub-id></element-citation></ref><ref id="B88-viruses-11-00131"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lobigs</surname><given-names>M.</given-names></name><name><surname>M&#x000fc;llbacher</surname><given-names>A.</given-names></name><name><surname>Regner</surname><given-names>M.</given-names></name></person-group><article-title>MHC class I up-regulation by flaviviruses: Immune interaction with unknown advantage to host or pathogen</article-title><source>Immunol. Cell. Biol.</source><year>2003</year><volume>81</volume><fpage>217</fpage><lpage>223</lpage><pub-id pub-id-type="doi">10.1046/j.1440-1711.2003.01161.x</pub-id><?supplied-pmid 12752686?><pub-id pub-id-type="pmid">12752686</pub-id></element-citation></ref><ref id="B89-viruses-11-00131"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glasner</surname><given-names>A.</given-names></name><name><surname>Oiknine-Djian</surname><given-names>E.</given-names></name><name><surname>Weisblum</surname><given-names>Y.</given-names></name><name><surname>Diab</surname><given-names>M.</given-names></name><name><surname>Panet</surname><given-names>A.</given-names></name><name><surname>Wolf</surname><given-names>D.G.</given-names></name><name><surname>Mandelboim</surname><given-names>O.</given-names></name></person-group><article-title>Zika Virus Escapes NK Cell Detection by Upregulating Major Histocompatibility Complex Class I Molecules</article-title><source>J. Virol.</source><year>2017</year><volume>91</volume><fpage>e00785-17</fpage><pub-id pub-id-type="doi">10.1128/JVI.00785-17</pub-id><pub-id pub-id-type="pmid">28878071</pub-id></element-citation></ref><ref id="B90-viruses-11-00131"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>Y.</given-names></name><name><surname>King</surname><given-names>N.J.</given-names></name><name><surname>Kesson</surname><given-names>A.M.</given-names></name></person-group><article-title>Major histocompatibility complex class I (MHC-I) induction by West Nile virus: Involvement of 2 signaling pathways in MHC-I up-regulation</article-title><source>J. Infect. Dis.</source><year>2004</year><volume>189</volume><fpage>658</fpage><lpage>668</lpage><pub-id pub-id-type="doi">10.1086/381501</pub-id><pub-id pub-id-type="pmid">14767820</pub-id></element-citation></ref><ref id="B91-viruses-11-00131"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drews</surname><given-names>E.</given-names></name><name><surname>Adam</surname><given-names>A.</given-names></name><name><surname>Htoo</surname><given-names>P.</given-names></name><name><surname>Townsley</surname><given-names>E.</given-names></name><name><surname>Mathew</surname><given-names>A.</given-names></name></person-group><article-title>Upregulation of HLA-E by dengue and not Zika viruses</article-title><source>Clin. Transl. Immunol.</source><year>2018</year><volume>7</volume><fpage>e1039</fpage><pub-id pub-id-type="doi">10.1002/cti2.1039</pub-id></element-citation></ref><ref id="B92-viruses-11-00131"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Daniel</surname><given-names>S.</given-names></name><name><surname>Huang</surname><given-names>Y.</given-names></name><name><surname>Chancey</surname><given-names>C.</given-names></name><name><surname>Huang</surname><given-names>Q.</given-names></name><name><surname>Lei</surname><given-names>Y.F.</given-names></name><name><surname>Grinev</surname><given-names>A.</given-names></name><name><surname>Mostowski</surname><given-names>H.</given-names></name><name><surname>Rios</surname><given-names>M.</given-names></name><name><surname>Dayton</surname><given-names>A.</given-names></name></person-group><article-title>Anti-West Nile virus activity of in vitro expanded human primary natural killer cells</article-title><source>BMC Immunol.</source><year>2010</year><volume>11</volume><elocation-id>3</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2172-11-3</pub-id><?supplied-pmid 20089143?><pub-id pub-id-type="pmid">20089143</pub-id></element-citation></ref><ref id="B93-viruses-11-00131"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quaresma</surname><given-names>J.A.</given-names></name><name><surname>Barros</surname><given-names>V.L.</given-names></name><name><surname>Pagliari</surname><given-names>C.</given-names></name><name><surname>Fernandes</surname><given-names>E.R.</given-names></name><name><surname>Guedes</surname><given-names>F.</given-names></name><name><surname>Takakura</surname><given-names>C.F.</given-names></name><name><surname>Andrade</surname><given-names>H.F.</given-names><suffix>Jr.</suffix></name><name><surname>Vasconcelos</surname><given-names>P.F.</given-names></name><name><surname>Duarte</surname><given-names>M.I.</given-names></name></person-group><article-title>Revisiting the liver in human yellow fever: Virus-induced apoptosis in hepatocytes associated with TGF-beta, TNF-alpha and NK cells activity</article-title><source>Virology</source><year>2006</year><volume>345</volume><fpage>22</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2005.09.058</pub-id><?supplied-pmid 16278000?><pub-id pub-id-type="pmid">16278000</pub-id></element-citation></ref><ref id="B94-viruses-11-00131"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurane</surname><given-names>I.</given-names></name><name><surname>Hebblewaite</surname><given-names>D.</given-names></name><name><surname>Brandt</surname><given-names>W.E.</given-names></name><name><surname>Ennis</surname><given-names>F.A.</given-names></name></person-group><article-title>Lysis of dengue virus-infected cells by natural cell-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity</article-title><source>J. Virol.</source><year>1984</year><volume>52</volume><fpage>223</fpage><lpage>230</lpage><pub-id pub-id-type="pmid">6207308</pub-id></element-citation></ref><ref id="B95-viruses-11-00131"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laoprasopwattana</surname><given-names>K.</given-names></name><name><surname>Libraty</surname><given-names>D.H.</given-names></name><name><surname>Endy</surname><given-names>T.P.</given-names></name><name><surname>Nisalak</surname><given-names>A.</given-names></name><name><surname>Chunsuttiwat</surname><given-names>S.</given-names></name><name><surname>Ennis</surname><given-names>F.A.</given-names></name><name><surname>Rothman</surname><given-names>A.L.</given-names></name><name><surname>Green</surname><given-names>S.</given-names></name></person-group><article-title>Antibody-dependent cellular cytotoxicity mediated by plasma obtained before secondary dengue virus infections: Potential involvement in early control of viral replication</article-title><source>J. Infect. Dis.</source><year>2007</year><volume>195</volume><fpage>1108</fpage><lpage>1116</lpage><pub-id pub-id-type="doi">10.1086/512860</pub-id><pub-id pub-id-type="pmid">17357046</pub-id></element-citation></ref><ref id="B96-viruses-11-00131"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>P.</given-names></name><name><surname>Morrison</surname><given-names>B.J.</given-names></name><name><surname>Beckett</surname><given-names>C.G.</given-names></name><name><surname>Liang</surname><given-names>Z.</given-names></name><name><surname>Nagabhushana</surname><given-names>N.</given-names></name><name><surname>Li</surname><given-names>A.</given-names></name><name><surname>Porter</surname><given-names>K.R.</given-names></name><name><surname>Williams</surname><given-names>M.</given-names></name></person-group><article-title>NK cell degranulation as a marker for measuring antibody-dependent cytotoxicity in neutralizing and non-neutralizing human sera from dengue patients</article-title><source>J. Immunol. Methods</source><year>2017</year><volume>441</volume><fpage>24</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1016/j.jim.2016.11.005</pub-id><?supplied-pmid 27856192?><pub-id pub-id-type="pmid">27856192</pub-id></element-citation></ref><ref id="B97-viruses-11-00131"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>K.M.</given-names></name><name><surname>Thompson</surname><given-names>B.S.</given-names></name><name><surname>Fremont</surname><given-names>D.H.</given-names></name><name><surname>Diamond</surname><given-names>M.S.</given-names></name></person-group><article-title>Antibody recognition of cell surface-associated NS1 triggers Fc-gamma receptor-mediated phagocytosis and clearance of West Nile Virus-infected cells</article-title><source>J. Virol.</source><year>2007</year><volume>81</volume><fpage>9551</fpage><lpage>9555</lpage><pub-id pub-id-type="doi">10.1128/JVI.00879-07</pub-id><?supplied-pmid 17582005?><pub-id pub-id-type="pmid">17582005</pub-id></element-citation></ref><ref id="B98-viruses-11-00131"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khandia</surname><given-names>R.</given-names></name><name><surname>Munjal</surname><given-names>A.</given-names></name><name><surname>Dhama</surname><given-names>K.</given-names></name><name><surname>Karthik</surname><given-names>K.</given-names></name><name><surname>Tiwari</surname><given-names>R.</given-names></name><name><surname>Malik</surname><given-names>Y.S.</given-names></name><name><surname>Singh</surname><given-names>R.K.</given-names></name><name><surname>Chaicumpa</surname><given-names>W.</given-names></name></person-group><article-title>Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection</article-title><source>Front. Immunol.</source><year>2018</year><volume>9</volume><fpage>597</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2018.00597</pub-id><?supplied-pmid 29740424?><pub-id pub-id-type="pmid">29740424</pub-id></element-citation></ref><ref id="B99-viruses-11-00131"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castanha</surname><given-names>P.M.S.</given-names></name><name><surname>Nascimento</surname><given-names>E.J.M.</given-names></name><name><surname>Braga</surname><given-names>C.</given-names></name><name><surname>Cordeiro</surname><given-names>M.T.</given-names></name><name><surname>de Carvalho</surname><given-names>O.V.</given-names></name><name><surname>de Mendon&#x000e7;a</surname><given-names>L.R.</given-names></name><name><surname>Azevedo</surname><given-names>E.A.N.</given-names></name><name><surname>Fran&#x000e7;a</surname><given-names>R.F.O.</given-names></name><name><surname>Dhalia</surname><given-names>R.</given-names></name><name><surname>Marques</surname><given-names>E.T.A.</given-names></name></person-group><article-title>Enhancement of Zika Infection by Dengue-Specific Antibodies Does Not Alter the Production of Interleukin 6 in Fc&#x003b3;RII-Expressing K562 Cells</article-title><source>J. Infect. Dis.</source><year>2017</year><volume>216</volume><fpage>614</fpage><lpage>615</lpage><pub-id pub-id-type="doi">10.1093/infdis/jix346</pub-id><?supplied-pmid 28931227?><pub-id pub-id-type="pmid">28931227</pub-id></element-citation></ref><ref id="B100-viruses-11-00131"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halstead</surname><given-names>S.B.</given-names></name></person-group><article-title>Neutralization and antibody-dependent enhancement of dengue viruses</article-title><source>Adv. Virus Res.</source><year>2003</year><volume>60</volume><fpage>421</fpage><lpage>467</lpage><pub-id pub-id-type="pmid">14689700</pub-id></element-citation></ref><ref id="B101-viruses-11-00131"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>P.</given-names></name><name><surname>Williams</surname><given-names>M.</given-names></name><name><surname>Nagabhushana</surname><given-names>N.</given-names></name><name><surname>Morrison</surname><given-names>B.J.</given-names></name></person-group><article-title>Combating Antibody-dependent Enhancement of Dengue Viral infection in Peripheral Blood Monocytes by NK Cell-mediated Antibody Dependent Cell Cytotoxicity</article-title><source>J. Immunol.</source><year>2017</year><volume>198</volume><fpage>122.11</fpage></element-citation></ref></ref-list></back><floats-group><fig id="viruses-11-00131-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Non-exhaustive alphabetic list of flaviviruses (in red) and alphaviruses (in blue) and their geographical localization. Flaviviruses: Bagaza virus (BAGV), Bamaga virus (BGV), Banzi virus (BANV), Bouboui virus (BOUV), Dengue virus (DENV), Israel Turkey meningoencephalomyelitis (ITV), Japanese encephalitis virus (JEV), Jugra virus (JUGV), Kokobera virus (KOKV), Lamni virus (LAMV), Murray Valley encephalitis virus (MVEV), Nouanam&#x000e9; virus (NOUV), Rabensburg virus (RABV), Saint Louis encephalitis virus (SLEV), Spondweni virus (SPOV), Tembusu virus (TMUV), T&#x02019;Ho virus (THOV), Usutu virus (USUV), Wesselsbron virus (WESSV), West Nile virus (WNV), yellow fever virus (YFV) and Zika virus (ZIKV). Alphaviruses: Barmah forest virus (BFV), Chikungunya virus (CHIKV), Mayaro virus (MAYV), O&#x02019;nyong-nyong virus (ONNV), Ross River virus (RRV), Semliki forest virus (SFV) and Sindbis virus (SINV).</p></caption><graphic xlink:href="viruses-11-00131-g001"/></fig><fig id="viruses-11-00131-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Virus dissemination, immune activation and clinical manifestations in patients infected by alphavirus or flavivirus. These viruses are transmitted through the bite of a female mosquito. The virus infects susceptible cells of the dermis, such as endothelial cells, fibroblasts and macrophages. Locally produced viral particles are then transported through the circulation to secondary lymphoid organs. This acute phase of infection is associated with the upregulation of the production of proinflammatory cytokines, such as IL-1&#x003b2; and IFN-&#x003b1;, that induce innate immune responses, including those exerted by NK cells. Through the circulation alphavirus or flavivirus disseminated also to different organs, including the brain, spleen, liver, joints and muscles. Peripheral and tissue-resident NK cells can directly fight infected cells by triggering cytotoxicity (alphaviruses) or massive production of IFN-&#x003b3; (flaviviruses), which contributes to the control of infection and the generation of adaptive T cell immunity, as well as the production of protective antibodies and the induction of antibody-dependent cellular cytotoxicity. For other flaviviruses, such as DENV, antibody complexes are also associated with the triggering of antibody-dependent enhancement which has been linked to the development of more severe forms of disease.</p></caption><graphic xlink:href="viruses-11-00131-g002"/></fig></floats-group></article>